Analysis of the Cellular Proteins, TIA-1 and TIAR, and their Interaction with the West Nile Virus (WNV) 3\u27 SL Minus-Strand RNA by Emara, Mohamed Maged
Georgia State University
ScholarWorks @ Georgia State University
Biology Dissertations Department of Biology
4-23-2007
Analysis of the Cellular Proteins, TIA-1 and TIAR,
and their Interaction with the West Nile Virus
(WNV) 3' SL Minus-Strand RNA
Mohamed Maged Emara
Georgia State University
Follow this and additional works at: https://scholarworks.gsu.edu/biology_diss
Part of the Biology Commons
This Dissertation is brought to you for free and open access by the Department of Biology at ScholarWorks @ Georgia State University. It has been
accepted for inclusion in Biology Dissertations by an authorized administrator of ScholarWorks @ Georgia State University. For more information,
please contact scholarworks@gsu.edu.
Recommended Citation
Emara, Mohamed Maged, "Analysis of the Cellular Proteins, TIA-1 and TIAR, and their Interaction with the West Nile Virus (WNV)
3' SL Minus-Strand RNA." Dissertation, Georgia State University, 2007.
https://scholarworks.gsu.edu/biology_diss/70
Analysis of the cellular proteins, TIA-1 and TIAR, and their interaction with the  
West Nile virus (WNV) 3’ SL minus-strand RNA 
by 
Mohamed Emara 
Under the Direction of Margo A. Brinton 
ABSTRACT 
The 3’ terminal stem loop of the WNV minus-strand [WNV3’(-) SL] RNA was 
previously shown to bind the cell protein, T-cell intracellular antigen-1 (TIA-1), and the 
related protein, TIAR. These two proteins are known to bind AU-rich sequences in the 
3’UTRs of some cellular mRNAs. AU stretches are located in three single-stranded 
loops (L1, L2, and L3) of the WNV3’(-) SL RNA. The RNA binding activity of both 
proteins was reduced when L1 or L2, but not L3, AU sequences were deleted or 
substituted with Cs. Deletion or substitution with Cs of the entire AU-rich sequence in 
either L1 or L2 in a WNV infectious clone was lethal for the virus while mutation of 
some of these nt decreased the efficiency of virus replication. Mutant viral RNAs with 
small plaque or lethal phenotypes had similar translational efficiencies to wildtype RNA, 
but showed decreased levels of plus-strand RNA synthesis. These results correlated well 
with the efficiency of TIA-1 and/or TIAR binding in in vitro assays.  
In normal cells, TIA-1 and TIAR are evenly distributed in the cytoplasm and 
nucleus. Between 6 and 24 hr after WNV infection, TIAR concentrated in the perinuclear 
region and TIA-1 localization to this region began by 24 hr. Similar observations were 
made in DV2 infected cells but at later times after infection. In infected cells, both 
  
 
 
 
proteins colocalized with dsRNA, a marker for viral replication complexes, and with viral 
non-structural proteins. Anti-TIAR or anti-TIA-1 antibody coimmunoprecipitated viral 
NS3 and possibly other viral nonstructural proteins. In response to different types stress, 
TIA-1 and TIAR recruit cell mRNA poly(A)+ into cytoplasmic stress granules (SG) 
leading to general translational arrest in these cells. SG were not induced by flavivirus 
infection and cells became increasingly resistant to arsenite induction of SG with time 
after infection. Processing Body (PB) assembly was also decreased beginning at 24 hr. 
These data suggest that the sequestration of first TIAR and then TIA-1 via their 
interaction with viral components in flavivirus infected cells inhibits SG formation and 
prevents the shutoff of host translation. 
 
 
INDEX WORDS: West Nile virus, minus-strand RNA, 3’stem loop RNA, protein 
binding sites, TIAR, TIA-1, NS3, processing body, stress granules, virus RNA 
replication. 
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CHAPTER I 
INTRODUCTION 
 
Classification and Medical Importance of Flaviviruses. 
Flaviviruses and alphaviruses were previously classified as members of the family 
Togaviridae. However, due to differences in the replication and assembly strategies 
(Westaway et al., 1980), as well as the genome structures (Rice et al., 1985) of 
flaviviruses and alphaviruses, flaviviruses were reclassified as members of the genus 
flavivirus within the family Flaviviridae. The family Flaviviridae currently includes two 
other genera, the pestiviruses and the hepaciviruses (Lindenbach and Rice, 2007). The 
genus flavivirus contains more than 68 members that are separated into twelve antigenic 
serogroups (Heinz et al., 2000). Some flaviviruses such as dengue virus (DV), Japanese 
encephalitis virus (JEV), yellow fever virus (YFV), West Nile virus (WNV), St. Louis 
encephalitis virus (SLEV), Murray Valley encephalitis virus (MVEV), and tick-borne 
encephalitis virus (TBEV), are important human pathogens. 
Most of the flaviviruses are transmitted to vertebrates via infected blood-sucking 
arthropods, and are therefore called arthropod-borne viruses or “arboviruses” 
(Lindenbach and Rice, 2007). Approximately 65% of the flaviviruses are transmitted by 
mosquitoes, 22% by ticks, and the remaining 13% have no known arthropod vector 
(Porterfield, 1996). All of the members of the YFV, DV, and JE serogroups are 
mosquito-borne. Neuroinvasiveness is a common feature of those flaviviruses that cause 
substantial human and animal disease. Symptoms include fever, meningitis, and 
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encephalitis. Although YFV can be prevented by vaccine, outbreaks and epidemics 
caused by YFV have risen dramatically in the recent years in South America and sub-
Saharan countries in Africa, because of the difficulties of vaccinating many at-risk 
populations (Monath, 1994). YFV infections have a mortality rate that can be as high as 
20%. DV infects 50-100 million humans annually in tropical and subtropical regions 
(Gubler, 2002). Symptoms range from a self-limiting febrile illness to the life threatening 
dengue hemorrhagic fever and dengue shock syndrome (DHF-DSS), with a mortality rate 
of ~10%. Members of the JEV serogroup such as JEV, WNV, SLEV, and MVEV, are 
responsible for periodic epidemics and scattered cases of human central nervous system 
(CNS) disease (Lindenbach and Rice, 2007). WNV is endemic in Africa, the Middle East, 
Europe, central Asia, and most recently, North America. WNV infections in the USA first 
occurred in the summer of 1999 (Asnis et al., 2000). In 2006, the Centers for Disease 
Control and Prevention (CDC) reported 4261 positive human WNV cases in the US. 
Also, the tick-borne flaviviruses, such as Powassan, louping ill, Kyasanur Forest Disease, 
Russian Spring-Summer encephalitis viruses, and TBEV cause human meningitis and/or 
encephalitis with a case fatality ranging from 1-30% (Shope, 1980).  
 
Virion Morphology and Composition. 
The flavivirus virion is spherical, enveloped and has a diameter of 40-60 nm 
(Murphy, 1980). The virion is composed of three structural proteins, the envelope (E) 
protein, the membrane (M) protein, and the capsid (C) protein; the E and M proteins are 
located in the lipid envelope of the virion, while the C protein forms the viral capsid 
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(Lindenbach and Rice, 2007). Cryo-electron microscopy data suggested that the virions 
have icosahedral symmetry (Heinz and Allison, 2000). Recent studies indicated that this 
symmetry is imposed by interactions between E surface proteins, rather than by 
interactions between capsid monomers (Kuhn et al., 2002). 
 
Flavivirus replication cycle. 
Flavivirus surface protein binds to unknown receptor(s) on the host cell surface 
followed by virus entry via receptor-mediated endocytosis (Fig. 1.1A). The viral 
nucleocapsid is subsequently released into the cytoplasm of the infected cells by acidic-
pH fusion of the virion envelop with the endosomal membrane (Gollins and Porterfield, 
1985; Gollins and Porterfield, 1986; Nawa, 1998). After uncoating of the nucleocapsid by 
an unknown process, the viral genome is released into the cell cytoplasm and is then 
translated into a single polyprotein (Fig. 1.1B). The poly protein is processed by viral and 
cellular proteases into the mature viral structural and nonstructural proteins (Fig. 1.1C) 
(Heinz et al., 1994). The genome RNA also serves as the template for transcription of the 
complementary minus strand RNA. The minus-strand RNA in turn serves as a template 
for the synthesis of genomic RNA. The minus-strand RNA is always present in infected 
cells in association with the plus-strand RNA in a replicative form (RF) (Fig. 1.1D) or a 
replicative intermediate (RI) (Fig. 1.1E) complex (Lindenbach and Rice, 2007). 
Flavivirus RNA synthesis is postulated to occur via asymmetric and semiconservative 
mode of replication (Chu and Westaway, 1985; Cleaves, Ryan, and Schlesinger, 1981). 
Each plus-strand RNA template is thought to synthesize only one minus-strand RNA at a 
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time forming the RF, while the minus-strand template is efficiently reinitiated and 
simultaneously synthesizes multiple copies of the plus strand RNA forming the RI. The 
synthesis of plus and minus-strand viral RNA is disproportionate; about 10 times more 
plus strand RNA than the minus-strand RNA is produced (Chu and Westaway, 1985). 
Flavivirus replication takes place in viral replication complexes located on membranes in 
the perinuclear region of the cytoplasm of infected cells.  
Flavivirus infection causes extensive rearrangement and proliferation of the 
cytoplasmic membranes present in the perinuclear region to provide an environment that 
enhances virus replication (Brinton, 2002; Lindenbach and Rice, 2007). Later in the 
infection cycle, these rearrangements induce the formation of smooth membrane vesicle 
clusters known as vesicle packets (VP), that are found associated with smooth 
endoplasmic reticulum (SER) or Golgi-like membranes (Mackenzie, Jones, and 
Westaway, 1999). VP appear to be associated with another randomly folded membrane 
structure, called convoluted membranes (CM) or paracrystalline arrays (PC) (Mackenzie 
et al., 1998). Previous studies showed that the viral RNA as well as the viral replication 
proteins are localized within the VP, suggesting that these structures might be sites of 
RNA replication (Mackenzie et al., 1998; Westaway, Khromykh, and Mackenzie, 1999). 
The viral serine protease NS3 and cofactor NS2B colocalize in the CM/PC structures 
indicating that these are sites of proteolytic processing (Westaway et al., 1997b). It is 
noteworthy that VP have only been observed at later times after infection, thus the site(s) 
of early viral RNA synthesis is still not known. 
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Although flavivirus packaging and release mechanisms are not well understood, 
electron microscopy studies demonstrated that progeny virion assemblies formed in the 
lumen of the ER (Lindenbach and Rice, 2007) (Fig. 1.1 G). Immature virions containing 
prM-E heterodimers are found in cytoplasmic vesicles (Fig. 1.1 G and H). Mature virions 
are generated in the trans-Golgi network via cleavage of the N-terminal portion of prM to 
M (Stadler et al., 1997; Wengler and Wengler, 1989) and mature virions are released 
from the infected cell by exocytosis after fusion of virion-containing cytoplasmic vesicles 
with the plasma membrane (Stollar, Stevens, and Schlesinger, 1966) (Fig. 1.1I). The 
release of the flavivirus particles from the infected cells starts at about 12 hr after 
infection. For WNV and JEV, maximal virus titers are produced by 24 hr after infection 
(Trent, Swensen, and Qureshi, 1969). 
 
Flavivirus genome organization. 
The WNV genome is a single-stranded RNA with positive polarity that is 
approximately 11 Kb in length (Rice et al., 1985).  It contains a type I cap at the 5’ end, 
but lacks a poly (A) tract at the 3’ end. The genome contains a single, long open reading 
frame and serves as the only viral mRNA in WNV infected cells. The viral mRNA 
encodes a single polyprotein, which is translated and co- and posttranslationally 
processed by viral and cellular proteases into three structural (C, M, and E) proteins and  
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Figure 1.1:  Flavivirus replication cycle. A. Attachment, entry, and uncoating. B. 
Polyprotein translation. C. Polyprotein processing. D. (-) RNA synthesis. E. Nascent (+) 
RNA synthesis. F. Transport of the structural proteins to membranes.  G. Virion 
assembly. H. Virion movement to the cell surface. I. Release of nascent virions.  See text 
for details.  Figure was taken from Brinton (2002).   
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seven nonstructural (NS1, NS2a, NS2b, NS3, NS4a, NS4b and NS5) proteins (Fig. 1.2) 
(Chambers et al., 1990).   
The terminal 5’and 3’noncoding regions (NCRs) of the WNV genome RNA are 96 
and 631 nucleotides (nts) long, respectively (Chambers et al., 1990). Previous studies 
have indicated that both the 3’ and 5’ terminal nucleotides of the flavivirus genome can 
form conserved stem-loop (SL) structures (Fig. 1.2) (Brinton and Dispoto, 1988; Brinton, 
Fernandez, and Dispoto, 1986; Chambers et al., 1990). The SL structure formed by the 
3’-terminal nts is more stable than the structure formed by the 5’-terminal nts. The 
conservation of the terminal structures as well as of short sequence elements within these 
structures among divergent flaviviruses suggest that they may function as cis-acting 
elements (Brinton, 2002). Evidence supporting the formation of a SL structure by the 
3’terminal nt of the complementary minus-strand (Shi, Li, and Brinton, 1996) was 
previously obtained by RNase structure probing. Deletion of either the 3’or 5’ terminal 
SL in flavivirus infectious clones was lethal strongly suggesting that these regions 
contain essential cis-acting elements for virus replication (Bredenbeek et al., 2003; 
Cahour et al., 1995; Men et al., 1996). Particular host cell proteins have previously been 
reported to bind specifically to regions within the 3’ and 5’ NCRs of a number of animal 
RNA virus genomes (Lai, 1998). The 3’-terminal structure of the WNV complementary 
minus strand RNA was previously reported to bind specifically to cell proteins. UV-
induced cross-linking studies indicated that the molecular masses of these RNA binding 
proteins were about 42, 50, 60, and 108 kDa. One of these proteins, p42, was identified as 
TIAR (Li et al., 2002).  TIAR is closely related to TIA-1. 
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Figure 1.2:  The WNV genome. Noncoding regions (terminal black lines), structural 
proteins (blue bars), and nonstructural proteins (red bars). See text for details.  Figure 
from Brinton (2002).   
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Structural proteins. 
The C protein. 
Mature C protein is produced by the cleavage of a hydrophobic region from the C 
protein precursor, designated anchored C (anch C), by the viral serine protease NS3 
(Amberg et al., 1994; Yamshchikov and Compans, 1994). Peptides in the hydrophobic 
region of anch C were reported to serve as signals for the translocation of prM into the 
endoplasmic reticulum (ER) lumen (Nowak et al., 1989). The mature C protein is small 
(~11 kDa) and contains highly basic residues in its N- and C-termini (Rice et al., 1985), 
that may facilitate its interaction with the genomic RNA during the formation of the 
ribonucleoprotein complex. The middle portion of mature C contains a hydrophobic 
region that facilities membrane association and this may play a role in virus assembly 
(Markoff, Falgout, and Chang, 1997). At late times after infection, the C protein was 
found in the cytoplasm as well as the nucleus of infected cells (Westaway et al., 1997a).  
 
The M protein. 
The M protein is the smallest protein (~8 kDa) in the virus particle. It is initially 
expressed as the precursor protein M (prM). prM is incorporated into immature virions. 
During egress of virions, prM is cleaved by the Golgi-network enzyme furin to generate 
the mature structural protein M (Stadler et al., 1997). The mature M protein consists of an 
ectodomain (~40 aa long) followed by two transmembrane domains (Chambers et al., 
1990; Lindenbach and Rice, 2007). Although M protein is not defined as the viral protein 
that binds to cell receptors, previous studies demonstrated that the M ectodomain can 
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induce neutralizing antibody response (Bray and Lai, 1991; Vazquez et al., 2002), 
suggesting that it can maintain protective immunity.  
 
The E protein.  
E is a type I integral membrane protein of ~ 53 kDa that is located on the outer 
surface of the virion. The E protein is thought to facilitate the binding and entrance of the 
virus particle into the cell by mediating fusion of the viral envelope with cellular 
membrane. In immature virions, the E protein forms a heterodimer with the prM protein 
to maintain the correct folding and stabilization of E until prM is cleaved by cellular 
protease to yield the mature virion (Heinz and Allison, 2000). The E protein contains six 
intramolecular disulfide bonds that are conserved among all flaviviruses (Rey et al., 
1995). A high-resolution crystal structure of a soluble fragment of TBE E protein showed 
that the mature E protein forms elongated head-to-tail homodimers that were prepared to 
lie fairly parallel with the virus envelope with the distal end of each monomer anchored 
in the membrane (Heinz and Allison, 2000). Each subunit of the E protein is divided into 
three domains (I, II, and III) that corresponded to previously defined antigenic domains 
(Mandl et al., 2000; Mandl et al., 1989). Several studies have demonstrated that the E 
protein contains the major determinants that elect neutralizing antibodies and generate a 
protective immune response (Lindenbach and Rice, 2007). 
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Nonstructural proteins. 
The flavivirus nonstructural proteins are multifunctional proteins (Mackenzie et al., 
1998). All seven of the nonstructural proteins were previously shown to be components 
of viral RNA replication complexes (Kapoor et al., 1995; Uchil and Satchidanandam, 
2003; Vasudevan et al., 2001). However, exactly how each of these viral nonstructural 
proteins is involved in the formation and functioning of the flavivirus replication 
complexes is not well understood.  
 
NS1.  
NS1 is a ~ 46 kDa glycoprotein, which is found both in the cytoplasm as well as on 
the surface of infected cells and is slowly secreted by mammalian cells (Smith and 
Wright, 1985). The NS1-E junction is cleaved by host signal peptidase after NS1 has 
been translocated into the lumen of the ER (Chambers et al., 1990). NS2A is cleaved 
from the C-terminal end of NS1 by an unknown host protease associated with the ER 
(Falgout and Markoff, 1995). Although, NS1 forms homodimers that are hydrophobic 
and membrane-associated (Smith and Wright, 1985; Winkler et al., 1989; Winkler et al., 
1988), it is not clear how NS1 associates with cell membranes. A Kunjin NS1 mutation 
that completely inhibited NS1 dimer formation (Hall et al., 1999), was shown to reduce 
the level of virus growth by 100-fold compared to wild-type virus, but had no effect on 
NS1 secretion (Hall et al., 1999). These observations indicate that NS1 dimerization 
enhances, but is not essential for its function in virus replication.  
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A role for NS1 in viral RNA replication (Lindenbach and Rice, 1997; Muylaert, 
Galler, and Rice, 1997) has also been reported. Studies with dual labeled cryosections 
showed that DV NS1 colocalized with viral dsRNA in VP, the most likely sites of RNA 
replication, in infected Vero cells (Mackenzie, Jones, and Young, 1996; Westaway et al., 
1997b). Moreover, the accumulation of both the positive- and the negative-strand RNA 
during the first phase of viral RNA synthesis was significantly reduced in cells infected 
with a mutant YFV that contained a large in frame deletion in the NS1 gene (Lindenbach 
and Rice, 1997). Providing wildtype NS1 in trans successfully complemented this mutant 
virus RNA and restored viral RNA replication to wildtype levels, suggesting that NS1 
plays functions prior to or early in minus-strand synthesis. However, the YFV NS1 
deletion mutant RNA could not be trans-complemented by a DV NS1 suggesting that the 
function of NS1 may be mediated by an interaction with another viral protein. Mutation 
in NS4A suppressed this defect, indicating that an interaction between NS1 and NS4A is 
required for viral RNA synthesis (Lindenbach and Rice, 1999). 
 
NS2A, NS2B, NS4A, and NS4B. 
The four small hydrophobic, nonstructural proteins (NS2A, NS2B, NS4A, and NS4B)  
are tightly associated with cytoplasmic membranes and together with NS3, NS5, and NS1 
were previously shown to be components of membrane bound viral RNA replication 
complexes located in the perinuclear region of infected cells. Little is known about the 
specific functions of these four proteins. 
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NS2A. 
NS2A is found in infected cells in two forms, the full-length protein of ~ 22 kDa and 
a smaller 20 kDa C-terminally truncated form (Chambers et al., 1990; Nestorowicz, 
Chambers, and Rice, 1994). It was previously shown that mutagenesis of the C-terminus 
of either full length or truncated NS2A was lethal for YFV replication (Nestorowicz, 
Chambers, and Rice, 1994). Cryo-immunogold staining studies showed that NS2A 
localized in VP, which is thought to be the site for virus RNA replication (Mackenzie et 
al., 1998). Also, a recombinant NS2A protein was previously reported to bind in vitro to 
NS3 and NS5 as well as to regions within the 3’ NCR of Kunjin virus genomic RNA 
(Mackenzie et al., 1998). Mutational analysis of NS2A in a Kunjin virus infectious clone 
indicated an essential role for this protein in virus assembly (Liu, Chen, and Khromykh, 
2003). A recent study using Kunjin virus subgenomic replicons, demonstrated that a 
single amino acid substitution in NS2A significantly reduced the viral inhibitory effect of 
interferon beta (Liu et al., 2004). Together these data suggest that NS2A may be involved 
in RNA packaging, RNA replication, and interference with the host cell immune 
response. 
 
NS2B. 
NS2B is ~ 14 kDa protein that has a conserved central hydrophilic domain flanked by 
two hydrophobic domains. It forms a stable complex with the viral serine protease (NS3), 
and functions as a cofactor for the serine protease activity (Chambers et al., 1993; 
Falgout, Miller, and Lai, 1993). The interaction between NS2B and NS3 is mediated by 
  
14
the central hydrophilic region of NS2B and the N-terminal region of NS3 (Chambers et 
al., 1993; Droll, Krishna Murthy, and Chambers, 2000; Falgout, Miller, and Lai, 1993). 
This viral protein complex mediates cleavage at the junctions between anch C/virion C, 
NS2A-NS2B, NS2B-NS3, NS3-NS4A, and NS4B-NS5 (Amberg et al., 1994; Cahour, 
Falgout, and Lai, 1992; Chambers, Grakoui, and Rice, 1991; Falgout et al., 1991; Zhang, 
Mohan, and Padmanabhan, 1992). Deletion analysis indicates that the 40 aa hydrophilic 
domain of NS2B is required for NS3 serine protease activity. Mutations within the 
hydrophilic region that disrupt the NS2B-NS3 interaction also abolish serine protease 
activity (Chambers et al., 1993; Clum, Ebner, and Padmanabhan, 1997; Droll, Krishna 
Murthy, and Chambers, 2000; Falgout, Miller, and Lai, 1993). The hydrophobic regions 
of NS2B are involved in anchoring NS2B to ER membranes (Clum, Ebner, and 
Padmanabhan, 1997). 
 
NS3. 
NS3 is a large (~70 kDa) multifunctional protein that has several enzymatic activities, 
which are required for polyprotein processing, viral RNA replication, and RNA capping 
(Westaway, Mackenzie, and Khromykh, 2003). The N-terminus of NS3 has serine 
protease activity (Lindenbach and Rice, 2007), which is activated only after interacting 
with NS2B. It was previously reported that the NS3-NS2B complex is associated with 
membranes and is required for efficient polyprotein processing. The C-terminal portion 
of NS3 contains helicase and NTPase activities (Borowski et al., 2001). The precise 
functions of these enzymes are not known yet, however, the helicase is thought to unwind 
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the 3’ terminal secondary structures, which are involved in template recognition. NS3 
not only has these two activities, but the C-terminal region also encodes RNA 
triphosphatase (RTPase) (Wengler and Wengler, 1993), which is postulated to 
dephosphorylate the 5’end of the viral RNA before its cap methylation by the 
polymerase NS5. In a previous study using coimmunoprecipitation and immunoblotting 
experiments a protein-protein interaction between NS3 and NS5 was demonstrated 
(Kapoor et al., 1995) and the NTPase (Cui et al., 1998; Yon et al., 2005) as well as 
RTPase (Yon et al., 2005) activities of a recombinant dengue NS3 were enhanced by the 
presence of NS5. These observations indicate that the interaction of NS3 and NS5 might 
regulate the activity of NS3 during virus replication. 
 
NS5. 
NS5 is the largest (103 kDa) and most highly conserved flavivirus protein. The C-
terminal portion of NS5 contains the eight RNA dependent RNA polymerase (RdRp) 
motifs, that are highly homologues to the sequences of the RdRps of other positive-strand 
RNA viruses (Koonin, 1993). Previous in vitro studies using purified recombinant NS5 
protein (Ackermann and Padmanabhan, 2001; Nomaguchi et al., 2004; Tan et al., 1996) 
confirmed the polymerase activity of NS5. Previous studies indicated that flavirus NS5 
performs de novo RNA synthesis (Ackermann and Padmanabhan, 2001; Selisko et al., 
2006). As concluded from comparison of the kinetics of the de novo RNA synthesis by 
different Flavivirdae members RdRps, DV RdRP showed a higher degree of 
conformational flexibility than that of the WNV RdRp in the transition process from 
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initiation to elongation (Selisko et al., 2006). In a recent study, the crystal structure of the 
WNV RdRp was determined and it was shown that this structure is similar to that of two 
other members of the family Flaviviridae, hepatitis C virus (HCV) and bovine virus 
diarrhea virus (BVDV) (Malet et al., 2007). The overall structure has the classic fold of 
an RdRP, which consists of palm, thumb, and finger domains as well as specific 
flavivirus features such as the priming loop that provides a platform which stabilizes the 
viral RNA initiation complexes during the de novo initiation of flavivirus RNA syntheisis 
(Malet et al., 2007). The N-terminal part of this protein contains a methyltransferase that 
is predicted to function as an RNA capping enzyme (Koonin, 1993). NS5 was shown to 
have both guanine-N-7 and ribose 2’-O methylation activities (Ray et al., 2006). A 
recent mutational analysis of the terminal 74 nt WNV5’(+)SL structure of WNV showed 
that the second and third nt of the viral genome as well as the bottom two helices of the 
WNV5’(+)SL RNA structure are required for  N-7 methylation. Also, a minimum 
sequence of 20 nt in the 5’(+)SL that includes the first and the second nt was essential 
for 2’-OH ribose methylation (Dong et al., 2007). Although the presence of the MTase 
domain did not influence RdRp activity (Selisko et al., 2006), mutagenesis studies 
confirmed that both RdRp (Khromykh, Sedlak, and Westaway, 1999) and MTase (Zhou 
et al., 2007) are required for WNV life cycle.  
 
TIA-1 and TIAR cellular proteins. 
 T-cell intracellular antigen-1 (TIA-1) and T-cell intracellular antigen related protein 
(TIAR) are two evolutionary, conserved, multifunctional proteins that have been reported 
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to regulate alternative splicing of particular pre-mRNAs, translationally silence some 
mRNAs, and sequester cytoplasmic mRNAs in stress granules (SG) (Kedersha and 
Anderson, 2002). Although first discovered in T cells, TIA-1 and TIAR are expressed in 
most types of cells, including brain, spleen, and macrophages, which are sites of 
flavivirus replication in vivo. Both proteins are found in the cytoplasm and the nucleus 
and shuttle between the two compartments (Beck et al., 1996). Both proteins were also 
shown to be essential for embryonic development (Beck et al., 1998; Piecyk et al., 2000). 
For homozygous TIAR knock outs, embryo lethality was 100% in BALB/c mice and 
90% in C57BL/6 mice. For TIA-1 knock outs in both strains, the rate of embryonic 
lethality was 50% (Piecyk et al., 2000). Attempts to knock out both proteins in mice were 
unsuccessful (Piecyk et al., 2000) and suppression of both TIA-1 and TIAR in DT40 
chicken cells resulted in cell death (Le Guiner, Gesnel, and Breathnach, 2003). 
Two isoforms of both TIA-1 and TIAR have been reported and are translated from 
alternatively spliced mRNAs (Fig. 1.3). The two isoforms of TIA-1 differ from each 
other by the presence (TIA-1a) or absence (TIA-1b) of a mini exon encoding an           
11–amino acid peptide within the RRM1. TIARa includes a mini exon that encodes a  
17–amino acid peptide within RRM1, whereas TIARb lacks this exon. The long isoforms 
of both proteins have molecular weights of ~ 42 kDa, whereas the short isoforms have 
molecular weights of ~ 40 kDa. It was previously shown that the two TIA-1 isoforms are 
equally abundant in cells, whereas the short isoform of TIAR is 6 times more abundant in 
cells than is the long isoform (Beck et al., 1996).  
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TIA-1 and TIAR are members of the RNA recognition motif (RRM) family of RNA 
binding proteins (Anderson, 1995). Both proteins contain three RRM domains near their 
amino termini and a glutamine rich domain at their carboxyl termini (Fig. 1.3). The 
glutamine rich domain is also called prion related domain (PRD), which shares structural 
and functional characteristics with the aggregation domains of mammalian and yeast 
prion proteins (Gilks et al., 2004). Each RNA-binding domain contains two-
ribonucleoprotein sequences (RNP 1 and RNP2) that are conserved among all RNA 
binding proteins. TIA-1 and TIAR proteins share 80% overall amino acid identity with 
the highest degree of similarity (91% identity) in the RRM domain 3 and the lowest 
degree of similarity (51% identity) in the carboxyl terminal domain (Kawakami et al., 
1992). Although RRM2 is sufficient for the specific binding of either protein to uridylate-
rich RNA, RRM1 and RRM3 enhance RRM2 RNA binding (Dember et al., 1996). In 
somatic cells, RRM2 and the first half of the C-terminal domain mediate TIA-1 and 
TIAR nuclear accumulation, whereas RRM3 facilitates nuclear export (Zhang et al., 
2005).  
TIA-1 and TIAR protein binding sites were previously mapped to AU-rich regions 
within the 3’UTRs of a subset of cellular mRNAs, that included TNF-α (Gueydan et al., 
1999; Piecyk et al., 2000), cyclooxgenase-2 (COX-2) (Cok et al., 2004; Dixon et al., 
2003), and β2-adrenegic receptor (β2-AR) (Kandasamy et al., 2005) mRNAs. For the 
TNF-α mRNA, TIAR binding was mapped to a 39 nt region within the 3’UTR that 
contained a 35 nt AU tract (Gueydan et al., 1999; Lewis et al., 1998). However, the 
minimal sequences required for protein binding were not fine mapped in any of these 
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3’UTRs. The 3’terminal region of the WNV complementary minus strand RNA differs 
from RNAs previously reported to bind to TIA-1 and TIAR in having AU rich sequences 
within loops of a secondary structure. This binding is mediated through the RRM2 
domain of TIA-1 and TIAR proteins. Kinetic studies showed that the binding activity of 
TIA-1 RRM2 for the WNV3’(-)SL RNA was 10 times lower than that of the TIAR 
RRM2 for this RNA (Li et al., 2002) .  
 
Stress granules. 
Mammalian stress granules (SG) are ribonucleoprotein aggregates or discrete 
cytoplasmic foci, which are formed in response to environmental stresses such as 
oxidative phosphorylation ER stress, and some viral infections (Fig. 1.4) (Anderson and 
Kedersha, 2006). Several cell proteins, including TIA-1, TIAR, and Ras-Gap-SH3 
domain-binding protein (G3BP) are involved in SG assembly (Anderson and Kedersha, 
2006). SG are sites at which transient storage of untranslated mRNAs takes place in 
stressed cells. The sequestration of these mRNAs in SG is initiated by the 
phosphorylation of eukaryotic translation initiation factor 2 α (eIF2α), a key regulatory 
factor in translation initiation, and this inhibits translation by preventing the assembly of 
active preinitiation complexes. After eIF2α phosphorylation occurs, TIA-1 and TIAR 
bind to the translationally inactive initiation complexes as well as to the mRNA poly(A)+ 
and self-aggregate forming SG (Kedersha and Anderson, 2002). Both the RRM domains 
and the PRD of TIA-1 were previously shown to be essential for SG formation (Gilks et  
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Figure 1.3: Schematic structure of TIA-1 and TIAR. RRM1 (blue), RRM2 (green), 
RRM3 (red), and the C-terminal glutamine rich prion related domain (yellow). Each 
RRM domain contains two ribonucleoprotein sequences (RNP 1 and RNP2). The 
positions of the additional mini peptides in the long isoforms of TIA-1 and TIAR are 
indicated by arrows.  
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al., 2004; Kedersha et al., 1999). A recombinant TIA-1 protein lacking the three RNA 
binding domains was unable to bind poly(A)+ RNA and recruit it to SG (Kedersha et al., 
1999). Deletion of the TIA-1 PRD inhibited protein aggregation and SG assembly (Gilks 
et al., 2004). In mammalian cells SG were found to be physically associated with another 
type of foci, known as processing bodies (PB) (Kedersha et al., 2005). PB are spheroid 
particles (Cougot, Babajko, and Seraphin, 2004; Kedersha et al., 2005; Wilczynska et al., 
2005) that were identified in the cytoplasm of eukaryotic cells (Bashkirov et al., 1997; 
Eystathioy et al., 2002; Eystathioy et al., 2003; Sheth and Parker, 2003) and were 
reported to contain components of the 5’-3’ mRNA degradation pathway such as 
decapping enzymes DCP1/2, 5’-3’ exonuclease XRN1 (van Dijk et al., 2002).  
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Figure 1.4: Translation initiation in the absence or presence of stress factors. (Green 
panels) in the absence of stress. (Red panels) in the presence of stress.  The assembly of 
translationally inactive initiation complexes lacking eIF2 allows the RNA-binding protein 
TIA-1 to redirect untranslated mRNAs from polyribosomes to SGs. Figure from 
Kedersha and Anderson (2002). 
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GOALS OF THIS DISSERTATION 
 
1. Mapping the binding site(s) of the TIA-1 and TIAR proteins on the WNV3’(-)SL 
RNA.  
Data from previous in vitro selection/amplification (SELEX) experiments showed 
that the two cellular proteins, TIA-1 and TIAR, bind to AU stretches in RNAs. However, 
the optimal RNA sequences recognized by TIA-1 in SELEX assays were not the same as 
those recognized by TIAR (Dember et al., 1996). In another previous study, the binding 
sites for both TIA-1 and TIAR in the 3’NCR of the tumor necrosis factor alpha (TNF-α) 
mRNA were mapped to a large fragment of AU-rich sequence containing clustered 
AUUUA pentamers (Gueydan et al., 1999). These cell mRNA binding sites for TIA-1 
and TIAR were considered to be linear. In the WNV3’(-)SL RNA, the AU rich 
sequences are located in single stranded loops (L1, L2, and L3) within a secondary 
structure. Because TIA- and TIAR are ARE-binding proteins, the AU sequences will be 
the initial mutation targets in experiments designed to identify nucleotides in the 
WNV3’(-)SL RNA required for TIA-1 and TIAR protein binding.   
Recombinant TIA-1 and TIAR proteins will be overexpressed in bacteria, purified, 
and used for the analysis of RNA-protein interactions in gel mobility shift assay 
experiments. The binding sites of both proteins will be mapped by measuring the relative 
binding activities of each purified protein for different WNV 3’(-)SL RNA mutant 
probes containing mutations and/or deletions in the three predicted single stranded loops. 
First, global mapping of the three loops will be done to determine which loop(s) is 
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essential for binding by deleting or replacing each loop separately or in combination with 
a track of C residues. Subsequently, fine mapping of the binding sites will be done by 
mutating A and U nt in the loops.   
 
2. Determine whether the mapped binding site nt are cis-acting in the context of a 
virus infection. 
Deletion of either the 3’or 5’ terminal SL in various flavivirus infectious clones was 
lethal, which strongly suggested that these regions contain essential cis-acting elements 
for virus replication (Bredenbeek et al., 2003; Cahour et al., 1995; Men et al., 1996). In a 
previous study, the growth of WNV in cells lacking TIAR was six to eight fold lower 
than in wild type cells. In  TIA-1 knock out cells, WNV grew to peak virus titers 6 hours 
later than in the wild type cells (Li et al., 2002). These results suggested that both 
proteins may play a role in the WNV replication cycle. To test this hypothesis more 
directly, mutations and/or deletions in the mapped TIA-1 and TIAR binding sites within 
the  WNV3’(-)SL will be introduced into the a WNV infectious clone to test the effect of 
these mutations on virus production. Those mutations and/or deletions found to have a 
negative effect on virus production will be also tested for their effect on the translational 
efficiency of the viral RNA in transfected BHK cells by detecting viral antigen 
production by immunoflourescence. The effect of mutations and/or deletions found to 
have a negative effect on virus production on the efficiency of viral plus-strand and 
minus-strand RNA synthesis will be quantified by real-time RT-PCR. 
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3. Determine whether the TIA-1/TIAR-viral RNA interactions occur in vivo and test 
the effect of WNV infection on cellular SG formation. 
In previous in vitro RNA-protein interaction assays, the TIA-1/TIAR proteins were 
shown to bind specifically to the WNV3’(-)SL RNA (Li et al., 2002). The minus-strand  
RNA of flaviviruses is present in infected cells only in RNA replication complexes 
(Lindenbach and Rice, 2007). An antibody to dsRNA that does not detect either cellular 
ribosomal RNA or tRNA was previously utilized to detect flavivirus replication 
complexes in infected cells (Miller, Sparacio, and Bartenschlager, 2006). To test whether 
TIA-1/TIAR colocalize with viral dsRNA and/or viral protein(s) in infected cells, BHK 
cells will be infected with WNV and incubated with anti-WNV hyperimmune serum or 
anti-dsRNA and anti-TIA-1 or anti-TIAR antibody and colocalization of cell and viral 
proteins will be analyzed by confocal microscopy. 
A number of detailed studies have shown that TIA-1 and TIAR are core components 
of SG and that they recruit cell mRNAs into cytoplasmic foci formed in response to stress 
factors (Kedersha et al., 2002). Sequestration of cell mRNAs in SG leads to repression of 
their translation until the cells recover from stress or die (Kedersha et al., 2002). To 
determine the effect of WNV infection on cellular SG formation, BHK infected with 
WNV will be treated with sodium arsenite to induce SG at different times after infection 
and SG will be detected by confocal microscopy.  
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CHAPTER II 
Mutation of mapped TIA-1/TIAR binding sites within the West Nile virus 3’ 
terminal minus-strand RNA sequence in an infectious clone negatively affects viral 
plus-strand synthesis. 
 
ABSTRACT 
The 75 nt 3’ terminal stem loop (SL) of the West Nile virus minus-strand  
(WNV3’(-)SL) RNA was previously shown to bind specifically to T-cell intracellular 
antigen-1 (TIA-1) and the related protein TIAR. TIA-1 and TIAR were also reported to 
bind specifically to relatively long AU-rich sequences in the 3’UTRs of some cellular 
mRNAs. Three single-stranded loops (L1, L2, and L3) in the predicted WNV3’(-)SL 
RNA secondary structure each contain a single short AU stretch. Both TIA-1 and TIAR 
recombinant proteins bound less efficiently in in vitro gel mobility shift assays to 
WNV3’(-)SL RNA with the L1 or L2 UAAUU sequences deleted or substituted with Cs. 
The minimal binding site for both proteins in either L1 or L2 was UAA. In contrast, 
neither deletion of UAA in L3 nor substitution of L3 with Cs affected the binding of 
either protein. Deletion or C substitution of the entire AU-rich sequence in either L1 or 
L2 within the 3’(-) SL RNA in a WNV infectious clone was lethal. Analysis of mutants 
with partial deletions or substitutions in these sequences showed that AU sequences were 
needed in both L1 and L2. Immunofluorescence imaging of viral RNA transfected cells 3 
hr post transfection showed that mutant viral RNAs with either small plaque or lethal 
phenotypes expressed similar amounts of viral proteins as wildtype RNA. In contrast, the 
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efficiency of plus-strand RNA synthesis correlated well with the efficiency of in vitro 
protein binding efficiency. Also, for each of the primary and secondary site revertants 
obtained, increased virus viability correlated with restoration of a protein binding site. 
These data support the hypothesis that the interaction between TIA-1/TIAR and the 
WNV3’(-)SL RNA facilitates the initiation of genome RNA synthesis from the minus-
strand template. 
 
INTRODUCTION 
West Nile virus (WNV) is a spherical, enveloped virion that belongs to the family 
Flaviviridae, genus flavivirus (Lindenbach and Rice, 2007). The WNV genome is a 
single-stranded positive sense RNA of approximately 11 kb in length. The viral genome 
has a 5’ type I cap, but no 3’ poly(A) tail. It contains a single, long open reading frame 
(ORF) and serves as the only viral mRNA during WNV replication. Viral replication 
takes place in the cytoplasm of the infected cells. The viral polyprotein is co- and 
posttranslationally processed by viral and cellular proteases into three structural (capsid, 
membrane and envelope) proteins and seven nonstructural [NS1, NS2a, NS2b, NS3, 
NS4a, NS4b, and NS5] proteins. The 5’end of the genome encodes the structural 
proteins, while the 3’ end of the genome encodes the nonstructural proteins (Lindenbach 
and Rice, 2007). The RNA genome also serves as the template for transcription of the 
complementary minus-strand RNA, which in turn serves as a template for the synthesis of 
nascent plus-strand genomic RNA. In infected cells, the minus-strand RNA is present 
only in association with the plus-strand RNA as a replicative form (RF) or a replicative 
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intermediate (RI) (Lindenbach and Rice, 2007). Previous evidence suggests that plus-
strand RNA templates synthesize only a single minus-strand RNA at a time (RF), while 
minus-strand templates are efficiently reinitiated simultaneously synthesizing multiple 
copies of plus-strand RNA (RI) (Chu and Westaway, 1985). Plus and minus-strand RNA 
synthesis is disproportionate. About 10 to 100 times more plus-strand RNA than the 
minus-strand RNA is produced (Brinton, 2002).  
The 5’noncoding region (NCR) of the WNV genome RNA is 96 nucleotides (nt) 
long while the 3’NCR is 631 nt in length (Chambers et al., 1990). Evidence supporting 
the formation of conserved stem-loop (SL) structures by the 3’terminal nt of the 
flavivirus genome (Brinton and Dispoto, 1988; Brinton, Fernandez, and Dispoto, 1986; 
Chambers et al., 1990) and the 3’ terminal nt of the complementary minus-strand (Shi, 
Li, and Brinton, 1996) was previously obtained by RNase structure probing. Deletion of 
either the 3’or 5’ terminal SL in flavivirus infectious clones was lethal strongly 
suggesting that these regions contain essential cis-acting elements for virus replication 
(Bredenbeek et al., 2003; Cahour et al., 1995; Men et al., 1996). Previous studies using 
purified in vitro expressed WNV NS5 in RdRP in vitro assay indicated that the terminal 
230 nt of the 3’minus-strand RNA alone is sufficient for plus-strand RNA synthesis 
(Nomaguchi et al., 2004). 
The WNV3’(-)SL RNA was previously reported to bind specifically to four hamster 
cell proteins of about 42, 50, 60, and 108 kDa (Shi, Li, and Brinton, 1996). p42 was 
identified as T-cell intracellular antigen related protein (TIAR) (Li et al., 2002). The 
closely related T-cell intracellular antigen-1 (TIA-1) protein (p42), was subsequently also 
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shown to bind to the WNV3’(-)SL RNA in gel mobility shift assays, but with a 10 fold 
lower efficiency (Li et al., 2002).  
Although first discovered in T cells, TIA-1 (Anderson et al., 1990) and TIAR 
(Kawakami et al., 1992) have subsequently been shown to be expressed in most types of 
cells and tissues (Beck et al., 1996; Jin et al., 2000). Both proteins are found in the 
cytoplasm and the nucleus and shuttle between these two compartments. These 
evolutionarily conserved cellular proteins are multifunctional and have been reported to 
regulate alternative splicing (Dirksen, Mohamed, and Fisher, 2003; Shukla et al., 2005; 
Shukla et al., 2004; Yu et al., 2003; Zhu et al., 2003), to silence translation (Dixon et al., 
2003; Kandasamy et al., 2005; Piecyk et al., 2000), to regulate Fas-mediated apoptosis 
(Li et al., 2004; Taupin et al., 1995; Tian et al., 1995), to sequester cytoplasmic mRNAs 
into stress granules (Kedersha et al., 2000; Kedersha et al., 1999) and  to be functionally 
important during embryonic development (Beck et al., 1998; Piecyk et al., 2000). For 
homozygous TIAR knockouts, embryo lethality was 100% in BALB/c mice and 90% in 
C57BL/6 mice. In both mouse strains, the rate of embryonic lethality for homozygous 
TIA-1 knockouts was 50% (Piecyk et al., 2000). Attempts to knockout both proteins in 
mice were unsuccessful (Piecyk et al., 2000) and suppression of both TIA-1 and TIAR 
expression in DT40 chicken cells resulted in cell death (Le Guiner, Gesnel, and 
Breathnach, 2003). 
TIA-1 and TIAR are members of the RNA recognition motif (RRM) family of RNA 
binding proteins (Anderson, 1995). Both proteins contain three N-terminal RRMs and a 
C-terminal glutamine-rich auxiliary domain (Kawakami et al., 1992; Tian et al., 1991). 
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The C-terminal domain was reported to be structurally similar to the prion domain (Gilks 
et al., 2004; Kawakami et al., 1992; Tian et al., 1991). TIA-1 and TIAR share 80% 
overall amino acid (aa) identity with the highest degree of similarity (91% identity) in the 
third RRM and the lowest (51% identity) in the C-terminal domain (Anderson, 1995; 
Beck et al., 1996; Kawakami et al., 1992). Although RRM2 is sufficient for the specific 
binding of either protein to linear uridylate-rich RNA in vitro, RRM1 and RRM3 enhance 
RRM2 RNA binding (Dember et al., 1996). In somatic cells, RRM2 and the first half of 
the C-terminal domain mediate   TIA-1 and TIAR nuclear accumulation, whereas RRM3 
facilitates nuclear export (Zhang et al., 2005).  
Two isoforms of both TIA-1 and TIAR are translated from alternatively spliced 
mRNAs (Beck et al., 1996). The two TIA-1 isoforms differ by the presence (TIA-1a) or 
absence (TIA-1b) of a mini exon encoding 11 aa within RRM1. TIARa includes a mini 
exon that encodes 17 aa within RRM1, whereas TIARb lacks this exon. The molecular 
masses of the long isoforms of both proteins are ~ 42 kDa, whereas those of the short 
isoforms are ~ 40 kDa (Beck et al., 1996). The two TIA-1 isoforms are equally abundant 
in cells, while the short isoform of TIAR is 6 times more abundant than the long isoform 
(Beck et al., 1996).  
 In this study, the binding sites for TIA-1 and TIAR within the WNV3’(-)SL RNA 
secondary structure were mapped to two short single-stranded AU sequences. Mutation 
of these sequences within a WNV infectious clone showed a correlation between in vitro 
binding and the efficiency of genomic RNA synthesis and virus production. Similar 
translation efficiencies were observed for wildtype and all of the mutant RNAs.  
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RESULTS 
Expression, purification, and RNA binding activities of recombinant TIA-1 and 
TIAR.  
A previous study reported a specific interaction between the WNV3’(-)SL RNA and 
both TIA-1 and TIAR but the protein binding sites within the viral RNA were not 
mapped (Li et al., 2002). TIA-1 and TIAR are ARE binding proteins and have been 
reported to regulate the translation of a subset of cell mRNAs by binding to 3’UTR AU-
rich sequences (Cok et al., 2004; Dixon et al., 2003). The WNV3’(-)SL RNA was 
predicted to contain three short (3 to 5 nt) AU stretches. The relative importance of each 
of these AU stretches for TIA-1/TIAR binding was investigated. For these studies, 
recombinant (r) TIA-1 and TIAR proteins were expressed from a pCRT7/CT-TOPO 
expression vector in E. coli Rosetta cells and partially purified on a cobalt affinity 
column as described in Materials and Methods (Fig. 2.1A). It was estimated that both 
recombinant proteins were purified to ~ 85% homogeneity. The presence of purified 
rTIA-1 or rTIAR protein was confirmed by Western blot analysis using protein specific 
polyclonal antibodies directed against the C-terminus of each protein (data not shown). 
The binding activities of the partially purified proteins were tested in gel mobility 
shift assays with a WNV3’(-) SL RNA probe as described in Materials and Methods. For 
TIAR, binding activity was detected at concentrations as low as 5 nM (Fig. 2.1B), 
whereas for TIA-1 concentrations of ~50 nM were required to detect binding (Fig. 2.1C). 
This 10-fold difference in binding activity was consistent with data previously reported 
for recombinant GST fusion proteins (Li et al., 2002). Aggregation of RNA-protein 
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complexes was observed with both proteins at concentrations of 40-50 nM or higher (Fig. 
2.1B and C). Competition gel-shift assays done as described in Materials and Methods 
were used to confirm the specificity of the interactions between the WNV3’(-)SL RNA 
and each of the recombinant proteins. For rTIA-1, a small amount of competition was 
observed only with the highest concentration of the non-specific competitors used [200 
fold excess of poly I/C (1.0 ng) (Fig. 2.1D, lane 2, left panel) or 100 fold excess of tRNA 
(20 nM) (Fig. 2.1D, lane 3, left panel)]. In contrast, competition was observed with 
concentrations of unlabeled WNV3’(-)SL RNA as low as 0.2 nM (Fig. 2.1D, right 
panel). The binding efficiencies of two additional viral RNA probes, WNV3’(+)SL and 
WNV5’(+)SL, were also tested in gel mobility shift assays. rTIA-1 showed no binding to 
WNV3’(+)SL RNA probe and very low binding to WNV5’(+)SL with the highest 
concentration of TIA-1  (Fig. 2.1E). Similar results were observed with rTIAR (data not 
shown). These results demonstrate that among the WNV terminal SL RNAs, only the 
WNV3’(-)SL RNA binds to TIA-1 and TIAR.   
 
Analysis of the WNV3’(-)SL RNA structure.  
Two alternative secondary structures,  3’(-)S1 and   3’(-)S2 (Fig. 2.1F), with similar 
minimum free energy values were predicted for the 3’terminal 75 nts of the WNV 
minus-strand RNA by M-fold version 3.1 (Zuker, 2003 ). The 3’(-)S1 structure, which 
contained three single-stranded loops, L1, L2, and L3 was similar to the one previously 
obtained from structure probing data by Shi et al. (1996). The 3’(-)S2 structure was 
similar to, but a mirror image of, the optimal structure predicted by M-fold for the first 75 
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nts of the complementary WNV5’(+)SL RNA (Fig. 2.1F). This structure was the optimal 
one predicted by M-fold when sequence lengths ranging from 75 to 3000 nt were folded 
and was also predicted by a whole WNV RNA genome (11,029 nts) fold (Personal 
communication, Drs. A. Palmenberg and J.-Y. Sgro, University of Wisconsin Madison). 
To test which of the two WNV3’(-)SL RNA predicted structures was the optimal one 
for binding to TIA-1 and TIAR, mutations were introduced to lock the structure into one 
or the other of the predicted conformations (L2→As and MS2 RNA; Fig. 2.1F). A single 
optimal M-fold secondary structure was predicted for each of these mutant RNAs. The 
four RNAs migrated to the same position on a denaturing gel (Fig. 2.1G, left panel), but 
on the non-denaturing gel (Fig. 2.1G, right panel), the wildtype WNV3’(-)SL RNA and 
the L2→As RNA migrated to similar positions, while both the WNV5’(+)SL and MS2 
RNAs migrated faster. When the binding efficiencies of TIA-1 and TIAR to the MS2 and 
L2→As RNAs were compared in gel mobility shift assays, minimal binding to the MS2 
probe was detected with the highest concentrations of either protein, but both proteins 
bound efficiently to the L2→As probe (data not shown). Both TIA-1 and TIAR were 
previously reported to bind to poly(A) (Taupin et al., 1995; Tian et al., 1991). However, 
TIA-1 binds to poly(A) more efficiently than does TIAR (Kawakami et al., 1992; Taupin 
et al., 1995). Consistent with these results substituting L2 with As did not alter TIAR 
binding activity but enhanced TIA-1 binding activity by 8% at a protein concentration of 
60 nM (data not shown). Since these results as well as those of Shi et al. (1996) indicated 
that 3’(-)S1 is the primary secondary structure of the WNV3’(-)SL RNA, this structure 
was used as the basis for designing mutant RNAs to map the protein binding sites.
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Figure 2.1. Purification and RNA binding activities of recombinant TIA-1 and 
TIAR proteins. (A) Purification of rTIA-1 and rTIAR proteins on a cobalt affinity 
column followed by separation of the  proteins by 10% SDS PAGE. Fractions of rTIAR 
(lanes 1 and 2) and rTIA-1 (lanes 3 and 4) eluted with 150 mM imidazole. Gel mobility 
shift assays done with increasing concentrations of (B) rTIAR and (C) rTIA-1 and a 32P-
WNV3’(-)SL RNA probe and analyzed on 5% non-denaturing polyacrylamide gels. 
Lane 1, Free probe (FP); Lanes 2-8, Probe plus the indicated concentration of purified 
protein. The positions of the RNA-protein complexes (RPC) are indicated by brackets. 
(D) Representative competition gelshift analyses using 600 nM rTIA-1 protein, 32P-
WNV3’(-)SL RNA and an excess of unlabeled non-specific competitor (left panel; Lane 
1, FP; Lane 2, poly I/C; Lane 3, tRNA) or increasing concentrations of unlabelled 
WNV3’(-)SL RNA (right panel; Lane 1, FP; Lane 2, Probe without competitor; Lanes 3–
5, Probe plus increasing concentrations of unlabelled specific competitor). (E) 
Representative gel mobility shift assays done with increasing concentrations of rTIA-1 
and a 32P-WNV5’(+)SL RNA probe (upper panel) or a 32P-WNV3’(+)SL RNA probe 
(lower panel). (F) Secondary structures predicted for the WNV3’(-)SL RNA sequence 
[3’(-)S1 and 3’(-)S2], the complementary WNV5’(+)SL RNA [5’(+)S], and two 
mutated WNV3’(-)SL RNAs (L2→As and  MS2). ∆G, minimum free energy values 
calculated for each structure. The three AU-rich loops (L1, L2, and L3) in the 3’(-)S1 
RNA are indicated by arrows. AU-rich sequences within these loops are in bold. 
Substituted nt within these RNAs are indicated by asterisks. G. Migration of four of the 
32P RNA probes on denaturing (left panel) and non-denaturing (right panel) 
polyacrylamide gels. Lanes 1 and 5, MS2; Lanes 2 and 6, L2→As; Lanes 3 and 7, 
WNV5’(+)SL; and Lanes 4 and 8, wildtypeWNV3’(-)SL.  
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Mapping the binding sites for the TIA-1 and TIAR proteins within the WNV3’(-)SL 
RNA.  
Both TIA-1 and TIAR were previously reported to bind specifically to AU-rich 
regions in the 3’UTRs of a subset of cell mRNAs and the binding region in the TNF-α 
mRNA was mapped to a 39 nt AU-rich sequence. The 7 AUUUA repeats within this 
sequence were hypothesized to be the protein binding sites (Gueydan et al., 1999; Lewis 
et al., 1998). Inspection of the predicted structures of the MS2 and WNV5’(+)SL RNA 
(Fig. 2.1F) indicated that the sequence of L3 was identical in the two structures and 
contained one AU stretch, 5’UAA3’. In addition to the AU sequence in L3, both the 
3’(-)S1 and L2→As structures contained AU or A stretches of 5 to 8 nt in L1 and L2. 
These observations suggested that TIA-1 and TIAR can recognize the single-stranded AU 
sequences in L1 and/or L2 of the  WNV3’(-)SL RNA, but not those in L3.  
The A and U nt in each loop were first replaced with Cs. These substitutions were 
introduced at positions 16 to 20 (5’UAAUU3’, L1→Cs), at positions 26 to 29 
(5’UAAU3’, L2→Cs), at positions 40 to 47 (5’ACUACUAA3’, L3→Cs), and at 
positions 16 to 20 plus 26 to 29 (L1+L2→Cs) (Fig. 2.2A). M fold analysis indicated that 
the predicted RNA secondary structure of the wildtype RNA was preserved in each of 
these mutants. These mutant RNAs were used as probes in gel mobility shift assays with 
the recombinant proteins. The gel mobility shift assays shown in this figure and in all 
subsequent figures are representative of three replicate experiments. The binding 
activities of both of the recombinant proteins for mutant RNAs L1→Cs and L2→Cs were 
significantly reduced (Fig. 2B, Lanes 7-10 and 12-15; Fig. 2.2C and D) as compared to 
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those for the wildtype RNA (Fig. 2B, Lanes 2-5; Fig. 2.2C and D). Even less efficient 
binding to the L1+L2→Cs RNA was detected with both proteins (Fig. 2.2B, Lanes 17-
20; Fig. 2.2C and D). In contrast, the mutant L3→ Cs RNA formed complexes with both 
proteins (Fig. 2.2B, lanes 22-25) as efficiently as the wildtype RNA (Fig. 2.2C and D).  
As an alternative strategy, deletions in each loop were made separately or in 
combination. Only 3 nt could be deleted in L1 (U16, U19, and U20, p∆L1) or in L3 (U45, 
A46, and A47, ∆UAAL3) without affecting the predicted RNA secondary structure, while 
all of L2 (∆L2) could be deleted (Fig. 2.3A). The reduction in binding observed for the 
p∆L1 and ∆L2 RNAs (Fig. 3B, lanes 7-10 and 12-15; Fig. 2.3C and D) was similar to 
that observed with the L1→Cs and L2→Cs RNAs (Fig. 2.2). No rTIA-1 RNA-protein 
complexes were detected with the p∆L1,∆L2 RNA (Fig. 2.3B, upper panel, lanes 17-20; 
Fig. 2.3C) and minimal rTIAR binding was detected with this RNA (Fig. 2.3B, lower 
panel, lane 20; Fig. 2.3D). As observed with the L3→ Cs RNA, the binding activities of 
both proteins for the ∆UAAL3 RNA were similar to those for the wildtype RNA (Fig. 
2.3B, lanes 22-25; Fig. 2.3C and D). These results indicate that AU sequences need to be 
present in both L1 and L2 for either TIA-1 and TIAR to bind efficiently to the     
WNV3’(-)SL RNA in vitro.   
     To determine the minimum sequence in each loop required for TIA-1 and TIAR 
binding, the nt deleted in the p∆L1 plus ∆L2 RNA were next sequentially restored. RNA 
with U20 restored was designated p∆L1+U,∆L2 and RNA with both U19 and U20 restored  
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Figure 2.2.  Effect of C substitutions in L1, L2, and L3 of the WNV3’(-)SL RNA on 
in vitro rTIA-1 and rTIAR binding activity. (A) Predicted secondary structures of the 
mutant RNAs. Substituted nt are indicated by asterisks. (B) Representative gel mobility 
shift assays with rTIA-1(upper panel) or rTIAR (lower panel) and each mutant RNA 
probe. Lanes 1-5, wildtype RNA; Lanes 6-10, L1→Cs RNA; Lanes 11-15, L2→Cs RNA; 
Lanes 16-20, L1+L2→Cs RNA; and Lanes 21-25, L3→Cs RNA. Gel mobility shift 
assays were done with increasing concentrations of each purified protein. In this and the 
subsequent figures the average percent RNA probe shifted was calculated from triplicate 
experiments and plotted against the concentration of (C) rTIA-1 or (D) rTIAR. Error bars 
indicate standard deviation of the mean. 
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Figure 2.3. Effect of deletions in L1, L2, or L3 of the WNV3’(-)SL RNA on in vitro  
rTIA-1 and rTIAR binding activity. (A) Predicted secondary structures of the mutant 
RNAs. Only U nucleotides in L1 and UAA in L3 could be deleted without altering the 
predicted RNA secondary structure. Deleted nt are indicated by wedges. (B) 
Representative gel mobility shift assays with rTIA-1 (upper panel) or rTIAR (lower 
panel) and each mutant RNA probe. Lanes 1-5, wildtype RNA; Lanes 6-10, RNA with 
Us deleted in L1; Lanes 11-15, RNA with L2 deleted; Lanes 16-20, RNA with Us in L1 
and L2 deleted; and Lanes 21-25, RNA with UAA in L3 deleted. (C) and (D) Percent 
RNA probe shifted.  
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was designated p∆L1+UU,∆L2 (Fig. 2.4A). A slight increase in the percent of RNA 
probe shifted was observed with the restoration of U19 and the restoration of both U19 and 
U20 further increased the binding efficiency of both proteins (Fig. 2.4C and D). 
Sequential restoration of U25, U26, A27, and A28 in the p∆L1,∆L2 RNA was done in RNA 
probes designated p∆L1,∆L2+U, p∆L1,∆L2+UU, p∆L1,∆L2+UUA, and 
p∆L1,∆L2+UUAA, respectively (Fig. 2.4B). No increase in the binding activity of either 
protein was observed until three nt (5’UUA3’) had been restored to either L1 or L2 of 
the p∆L1,∆L2 RNA (Fig. 2.4E and F). Further increases in the binding activities of both 
proteins were observed with the p∆L1,∆L2+UUAA, ∆L2, and p∆L1 RNAs (Fig. 2.4E 
and F). As expected the binding activity observed with all of these RNAs was less 
efficient than when two functional binding sites were present. 
 
Effect of substitution of L1 and L2 with Cs on virus production.  
The mapping experiments described above indicated that the AU sequences in both 
L1 and L2 are required for efficient TIA-1 or TIAR binding to the WNV3’(-)SL RNA. 
The previous observation that the replication of WNV was reduced by 6- to 8-fold in 
TIAR knockout cells compared to control cells (Li et al., 2002) suggested that this viral 
RNA-cell protein interaction played a role in virus replication. To test this hypothesis 
more directly, mutations and/or deletions were introduced into L1 and/or L2 in a WNV 
infectious clone. Cs were substituted for Us or As in L1 or L2. First, individual 
substitutions were introduced at positions U16, A18, and U20 in L1 to generate L1U16→C,  
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Figure 2.4.  Effect of sequential restoration of deleted nt in L1 and L2 on in vitro 
rTIA-1 and rTIAR binding activity. Predicted secondary structures of (A) U19 and U20 
or (B) U25, U26, A27, and A28 sequentially restored in p∆L1,∆L2 RNA. Restored nt are 
indicated by asterisks. (C), (D), (E), and (F) Percent RNA probe shifted.  
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L1A18→C, and L1U20→C RNAs (Fig. 2.5A), respectively, and at positions U25, U26, 
A27, and U29 in L2 to create L2U25→C, L2U26→C, L2A27→C, and L2U29→C RNAs 
(Fig. 2.5C), respectively. None of these mutations were predicted to alter the secondary 
structure of the WNV3’(-)SL RNA. The L1U16→C viral RNA produced virus with a 
small plaque phenotype, whereas pinpoint plaques were observed with L2A27→C and 
L1A18→C RNAs (Fig. 2.5B and D). After one passage, sequence of these mutants and 
for L2A27→C also on the transfection plate, large plaques similar in size to those of the 
wildtype virus were observed and sequence analysis of the viral RNA extracted from 
these plaques showed that the introduced mutation had reverted to the wildtype sequence. 
An altered 3’(-)SL structure was predicted for (L1U19→C) (Fig. 2.5A), which was 
similar to that of MS2 (Fig. 2.1F). Only a few pinpoint plaques were observed by 72 hr 
after transfection of this RNA (Fig. 5B). After the first passage, large size plaques were 
observed and analysis of the sequence of viral RNA extracted from these plaques showed 
that C19 had reverted to the wildtype U. In contrast, L1U20→C, L2U26→C, and 
L2U29→C had no effect on plaque size or virus growth (Fig. 2.5B and D). 
No plaques were detected at 72 hr after transfection of a viral RNA that had both U16 
and A18 substituted with Cs (L1U16+A18→C) (Fig. 2.5B), but after one passage, both 
small plaques and pinpoint plaques were observed (data not shown). In RNA extracted 
from the small plaques, C16 had reverted to the wildtype U. In RNA extracted from the 
pinpoint plaques, C18 had reverted to the wildtype A. These two revertants were found in 
about equal abundance. Viral RNA containing both A27 and U29 substituted with C 
(L2U27+U29→C) produced virus with a pinpoint plaque phenotype. After one passage, 
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large plaques were observed (Fig. 2.5D) and in RNA extracted from these plaques only 
C27 had reverted to the wildtype A27 (equivalent to L2U29→C). Finally, substitutions 
were introduced at positions 16 through 20 (L1→Cs) (Fig. 2.5A), at positions 25 through 
29 (L2→Cs), and at positions 40 through 47 (L3→Cs) (Fig. 5C). As observed with the 
p∆L1, ∆L2, or ∆L3 RNAs, the L1→Cs, L2→Cs and L3→Cs mutants were lethal (Fig. 
2.5B and D). The observation that the mutations L1A18→C, L2U27→C, and 
L2U27+U29→C had a pinpoint plaque phenotype even though they had only two 
consequtive As or Us in either L1 or L2 suggested that when the AU sequence of one of 
these loops is intact, 2 nt of AU sequence in the other loop or either side of a C provided 
a sufficient amount of TIA-1 and TIAR binding to give a low level of virus production 
(pinpoint plaques). To test this hypothesis, L1A18→C, L2U27→C, and L2U27+U29→C 
3’(-)SL RNAs were transcribed and used as probes in gel mobility shift assays with 
rTIA-1 or rTIAR. Both proteins bound less efficiently to these mutant RNAs than to the 
wild type RNA. Decreases of 7, 8, and 13% in the binding activity of rTIAR (60 nM) 
were observed with L2U27→C, L1A18→C, and L2U27+U29→C mutant RNAs, 
respectively, as compared to the wild type RNA (data not shown). The binding activity of 
rTIA-1 (600 nM) for the L2U27→C, L1A18→C, and L2U27+U29→C mutant RNAs 
was 9, 11, and 15% lower than that for the wild type RNA, respectively (data not shown). 
These results confirm that TIA-1 and/or TIAR binding could also occur when a single C 
interrupted the AU stretches in either L1 or L2. 
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Figure 2.5. Effect of C substitutions in L1, L2, or L3 of the WNV3’(-)SL RNA on 
virus production. (A) and (C) Predicted secondary structures of the mutant RNAs. 
Substituted nt are indicated by asterisks. (B) and (D) Plaques produced by either the 
wildtype infectious clone RNA or the mutant RNAs by 72 hr on an RNA transfection 
well.  
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Effect of deletion of A and U nt in the mapped WNV3’(-)SL RNA TIA-1 and 
TIAR binding sites in a WNV infectious clone.  
As an alternative mutational strategy, deletion of each loop was done separately or in 
combination (Fig. 2.6A and C). Only 3 nt could be deleted in L1 (U16, U19, and U20, 
p∆L1), while all of L2 could be deleted (∆L2), without affecting the predicted RNA 
secondary structure (Fig. 2.6C). Deletion of both U19 and U20 in L1 or 5’UAAUU3’in 
L2 created the L1∆U19U20 and L2∆UAAUU RNAs, respectively (Fig. 2.6A and C). BHK 
monolayers were transfected with wildtype or mutant infectious clone RNA as described 
in Materials and Methods and virus plaques produced by 72 hr after transfection in the 
overlayed transfection plates were assayed. No plaques were observed in plates 
transfected with p∆L1, ∆L2, L1∆U19U20, or L2∆UAAUU RNA (Fig. 2.6B and D).   
To test whether any of the mutant RNAs that produced no plaques by 72 hr after 
transfection still grew to a low level and could revert, culture media harvested from a 
non-overlayed duplicate well was serially passaged three times in BHK cells and the 
infectivity of the 72 hr harvest from each passage was assessed by plaque assay. Also, the 
viral RNA in each passage supernatant was extracted, amplified by RT-PCR, and the 
cDNA was sequenced. For p∆L1 and ∆L2, neither viral plaques nor viral RNA was 
detected after any of the passages. In contrast, after the first passage, large plaques were 
observed with L1∆U19U20, while pinpoint plaques were observed with L2∆UAAUU (Fig. 
2.6B and D). RNA extracted from the L1∆U19U20 large plaque virus contained a second 
site mutation G21 to A (RG21) (Fig. 2.6A), whereas RNA extracted from the ∆UAAUUL2 
pinpoint plaque virus contained a second site mutation G24 to a U (RG24) (Fig. 2.6C). 
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Both of these mutations altered the secondary structure so that either three adjacent As or 
Us were present in the loop that was mutated (Fig. 2.6A and C). In RG21, the G21A 
mutation created a new L1 sequence of 4 nt (5’UAAA3’) and reduced the number of 
base pairs between L1 and L2 from 4 to 3. In contrast, in RG24, L1 was reduced from 5 
to 3 nt (5’UAA3’) and the other 2 nt (5’UU3’) in L1 became part of the stem between 
L1 and L2 (5’UUU3’), L2 increased from 4 to 7 nt, and the number of base pairs 
between L1 and L2 decreased by 1. Deletion of a single U from either L1 or L2 (U20 in 
L1, L1∆U20 or U25 in L2, L2∆U25) or 2 Us from L2 (U25 and U26, L2∆U25∆26) had no 
effect on virus growth (Fig. 2.6B and D). In each of these mutants, a minimum sequence 
of UAA was still present in both L1 and L2. AU sequences in L1 and L2 that were 3 nt in 
length gave detectable TIA-1 and TIAR binding in vitro, but viral RNA with an AU 
sequence in only L1 or L2 was not viable. These results suggested that the minimal levels 
of TIA-1/TIAR in vitro binding detected when 2 or 3 AU nt were present in L1 or L2, 
was not sufficient to support virus production. Although deletion of 5’UAA3’ in L3 
(∆L3) had no effect on TIA-1 and TIAR binding in vitro (see Fig. 2.3), this deletion was 
lethal in the infectious clone (Fig. 2.6D), suggesting that the L3 sequence or its 
complement may be involved in other essential interactions.   
 
Effect of mutations in the WNV3’(-)SL RNA on the viral RNA translation.  
Although the sequence of the terminal SL at the 5’end of the genome is 
complementary to that of the WNV3’(-)SL RNA the optimal predicted structures formed 
by these sequences are not mirror images due to G-U base pairing. Mutations introduced  
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Figure 2.6. Effect of deletion of A and U nucleotides in L1, L2, or L3 of the 
WNV3’(-)SL RNA on virus production. (A) and (C) Predicted secondary structures of 
the mutant and the second site mutant RNAs. Only the U nucleotides in L1 and UAA in 
L3 could be deleted without altering the predicted RNA secondary structure. Deleted nts 
are shown in wedges. Second site mutations are indicated by asterisks. (B) and (D) 
Plaques produced by either the wildtype infectious clone RNA, the mutant RNAs, or 
second site mutant RNAs by 72 hr on an RNA transfection well. 
L2U29→CL2U26→C
Stable
L2U25→C
Stable Stable
Stable
Wildtype L1U20→C L1U19→CL1U16→C L1A18→C
L2A27→C
A.
B.
C.
D. L3→Cs
Lethal
L1→Cs
Lethal
L1U16 +A18→Cs
L2 →Cs
Lethal
L2A27+U29→C
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A GC
A
A
U
C C U C
UU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
20
40
60
L1
L2
L3 C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
A
A
U
C C UC
UU
A
U
U
A C
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
A
A
U
C C UC
UU
C
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
A
A
U
C C UC
UU
A
C
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
A
A
U
C C UC
UU
C
U
U
A C
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
A
A
U
C C UC
UU
C
C
C
C C
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
**
*
*
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
C
A
U
C C UC
UU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A GC
A
A
C
C C UC
UU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A GC
A
A
U
C C UC
UC
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A GC
A
A
U
C C UC
CU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A GC
C
A
C
C C UC
UU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
C
C
C
C C UC
CC
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
***
*
*
C
C
C
C
C
C
CC
AG
U
A
UA
UA
U
A GC
A
A
U
C C UC
UU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
*
* *
*
*
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A GC
C
C
U AC
A
GC
C
U
U
U
A
C
C
C
UU
UU
U
G
G
G
U A
A A
5’ 3’
. .. .
*
  
62
in the WNV3’(-)SL RNA therefore might alter the complementary 5’(+)SL RNA, which 
in turn could affect the efficiency of translation initiation from the 5’ sequence of the 
genomic RNA. To determine the effect of the L1 or L2 mutations on viral RNA 
translation, BHK cells were transfected with either wildtype RNA or selected mutant 
viral RNAs. At 3 hr posttransfection, cells were fixed, permeabilized, incubated with 
anti-WNV hyperimmune serum, and then visualized by immunofluorescence microscopy 
as described in Materials and Methods. After transfection with wildtype RNA, bright 
WNV protein staining was observed throughout the cytoplasm in about 90% of the cells 
(Fig. 2.7A). No fluorescence was observed in the mock-infected cells. A similar 
distribution of viral antigen as well as a similar intensity of fluorescence (Fig. 2.7A) was 
detected after transfection of either L1U16→C RNA, which produced small plaques, 
L1A18→C RNA, which produced pin point plaques, L2∆U25 RNA, which produced 
wildtype plaques, p∆L1, ∆L2, and L1→Cs RNAs, all of which had a lethal phenotype, 
indicating that none of these mutations introduced affected translation efficiency. 
 
Relative quantification of viral RNA replication by real-time RT-PCR.  
The WNV3’(-)SL RNA is thought to contain cis-acting elements for the initiation of 
plus-strand RNA synthesis and if this is the case, mutations in this region would be 
expected to affect the efficiency of plus-strand RNA synthesis. To determine the effect of 
mutations in the WNV3’(-)SL L1 and L2 regions on plus-strand RNA synthesis, total 
cell RNA was extracted from BHK cells at 6, 48, and 72 hr after transfection with 
wildtype or selected mutant viral RNAs and the amount of viral plus-strand RNA was 
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quantified by real-time RT-PCR using primers targeting the NS1 region. GADPH mRNA 
was used to normalize variation between samples and the viral RNA levels were 
normalized to the amount of input viral RNA detected at 6 hr post transfection. After 
transfection of the wildtype RNA, an increase in intracellular plus-strand RNA over input 
RNA was observed by 48 hr and further increased by 72 hr post transfection (Fig. 2.7B). 
Similar plus-strand RNA levels were observed with the L2∆U25 mutant RNA, which 
produced wildtype plaques. With the L1U16→ C mutant RNA, which produced small 
plaques, about 10-fold less plus-strand RNA was detected by 72 hr after transfection (Fig. 
2.7B). Even ~30-fold less plus-strand RNA levels were detected by 72 hr with L1A18→ 
C mutant RNA, which produced pinpoint plaques (Fig. 2.7B). No increase in plus-strand 
RNA over input viral RNA was observed after transfection of the three RNAs with lethal 
mutations, p∆L1, ∆L2, and L1→Cs (Fig. 2.7B). Intracellular viral minus-strand RNA 
levels were quantified at 2, 12, and 24 hr after transfection of wildtype or mutant RNA 
using a strand-specific real-time RT-PCR protocol as described in Materials and 
Methods. Minus-strand RNA levels were calibrated to the amount of signal detected at 2 
hr after transfection, the majority of which was due to non-specific detection of plus-
strand input RNA. Therefore this normalization stringently removed nonspecific 
background. An increase in the levels of minus-strand RNA over background was 
observed at 12 hr after transfection with wildtype RNA and further increased by 24 hr. 
The minus-strand RNA levels detected for both of the mutant RNAs L1U16→ C and 
L2∆U25 were similar to those for the wildtype RNA (Fig. 2.7C). With the L1A18→ C  
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Figure 2.7. Effect of the introduced mutations in L1 or L2 within the WNV3’(-)SL 
RNA on viral RNA transcription and/or translation. (A) Immunofluorescences 
imaging of BHK cells that were transfected with wt-, or mutant infectious clone RNA or 
mock-transfected, and at 3 hr were fixed, permeabilized and incubated with anti-WNV 
hyperimmune serum (red). Nuclear DNA (blue) was stained with Hoechst 33258 dye. (B) 
Relative quantification of the levels of the intracellular viral genomic RNA at 6, 48, and 
72 hr post transfection of BHK cells with either wildtype or mutant infectious clone RNA 
by quantitative real-time RT-PCR. (C) Relative quantification of the levels of viral 
minus-strand RNA at 2, 12, and 24 hr post transfection of either wildtype or mutant 
infectious clone RNA by strand-specific, real-time RT-PCR.  
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mutant RNA, which produced pin point plaques, about 4-fold less minus-strand RNA was 
detected by 12 and 24 hr after transfection (Fig. 2.7C). No increase in the minus-strand 
RNA levels over background was observed after p∆L1 RNA transfection (Fig. 2.7C). 
These results showed that the levels of plus-strand RNA synthesis but not of minus-
strand RNA correlated well with mutant virus viability as well as with the relative 
efficiency of TIA-1 and/or TIAR binding in in vitro assays. 
 
DISCUSSION 
A previous study reported that the cellular proteins, TIA-1 and TIAR, bound 
specifically to the WNV3’(-) SL RNA (Li et al., 2002). In the present study, the binding 
sites on the WNV3’(-)SL RNA required for efficient in vitro TIA-1 and TIAR binding 
were fine mapped to two single-stranded UAAUU sequences present in opposite 
orientation in two adjacent loops, L1 and L2 and a minimum sequence of two A and/or U 
nt was shown to be required for detectable protein binding to the WNV3’(-)SL RNA 
probe. This is the first study to fine map binding sites for these proteins. 
Although the WNV5’(+)SL RNA contains AU sequences complementary to the TIA-
1 and TIAR binding sites in the WNV3’(-)SL RNA, neither protein bound to the 
5’(+)SL RNA. Similar results were obtained with the 3’(-)SL mutant RNA, MS2, which 
has a predicted structure similar to that of the WNV5’(+)SL. In both of these RNAs, the 
AU sequences were located in double-stranded regions. These observations indicate that 
TIA-1 and TIAR recognize AU sequences only when they are single-stranded. A 
previous SELEX study identified 20 RNA sequences that bound to TIA-1 and 20 that 
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bound to TIAR from random pools of RNA sequences (Dember et al., 1996). About 90% 
of these RNAs contained at least one U tract of 3 to 11 nts but all of them contained one 
or more AU sequences. Based on their frequency, the authors proposed that at least one U 
stretch of at least 3 nts in length was essential for TIA-1 and TIAR protein binding. 
However, they did not predict the structures of these RNAs. Folds generated using M-
fold, version 3.1 (data not shown) for these SELEX selected RNA sequences indicated 
that there were two or more single-stranded loops in each of these RNA. The majority of 
these loops contained AU sequences and a few contained U stretches, suggesting that 
various AU sequences as well as U tracts were the TIA1- or TIAR binding sites in these 
RNAs. 
According to the ARE-mRNA database (ARED) (http://rc.kfshrc.edu.sa/ared/), ARE-
mRNAs are classified in one of five clusters depending on the number of canonical 
AUUUA motifs within their 3’UTRs. mRNAs in clusters I, II, III, and IV contain five, 
four, three, or two overlapping AUUUA motifs, respectively, whereas cluster V mRNAs 
contain only one AUUUA. The WNV3’(-)SL RNA does not contain an AUUUA 
consensus sequence but has two UAAUU sequences that are present in opposite 
orientation to each other and separated by four base pairs (Fig. 2.1F, 3’(-)S1). The results 
of the present study indicate that TIA-1 and TIAR can bind efficiently to the      
WNV3’(-)SL RNA only when two UAAUU sequences are present in L1 and L2. A 
previous study using Sendai virus RNA showed that TIAR can bind to the viral genome 
trailer sequence UUUUAAAUUUU. This sequence also does not contain a AUUUA 
motif (Iseni et al, 2002). Among the cell mRNAs reported to bind TIA-1 and TIAR, the 
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3’UTRs of both TNF-α and COX-2 mRNAs have been classified as cluster III ARE 
sequences (http://rc.kfshrc.edu.sa/ared/). TIA-1 also binds to the 3’UTR of cytochrome c 
(Kawai et al., 2006), which has been classified as a cluster V ARE sequence and both 
TIA-1 and TIAR were reported to bind to the 3’UTR of the β2-AR mRNA (Kandasamy 
et al., 2005), which does not contain any conconical AUUUA sequences. Differences in 
the relative binding activities of TIA-1 and TIAR for different mRNAs could be mediated 
by different AU sequences.  
A significant decrease in the binding of either TIA-1 or TIAR was observed when 
either AU nt in L1 or L2, but not L3, was deleted. L1 and L2 each contain a UAAUU 
sequence whereas L3 contains UAA. TIA-1 and TIAR each contain three adjacent N-
terminal RRMs. It is not known how many of these RRMs interact with regions of an 
RNA during an efficient RNA-protein interaction. The spacing as well as the spatial 
orientation of multiple single-stranded binding sites presented in the context of an RNA 
structure may be important in determining how many of the RRMs contact an RNA. 
Evidence from the present study suggests that one TIA-1 or TIAR molecule can 
simultaneously contact the WNV3’(-) SL RNA at both the L1 and L2 AU sequences. 
The UAA in L3 is located at the 3’ end of this loop and may not be in an optimal spatial 
orientation on the RNA helix for protein binding or alternatively, it may be located too 
far away from L2 for an RRM to bind at this site. 
The binding activity of both TIA-1 and TIAR was affected to a greater degree by 
deletion or mutation of L2 than by the same changes in L1. The larger size of L2 may 
provide increased flexibility required for an efficient protein interaction. Recent structural 
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analyses of RNA-protein complexes formed between polypyrimidine tract binding 
protein, a protein with four RNA binding domains (RBDs), and pre-mRNAs showed that 
each of the four RBDs bound to a separate pyrimidine tract in the same pre-mRNA 
forming bridges that looped out regions of sequence thus protecting them from splicing 
(Oberstrass et al., 2005). RRM2 in both TIA-1 and TIAR has been shown to account for 
the majority of the binding activity for short U-rich RNAs, but the binding affinity of 
both proteins increased when either of the other two RRMs was present (Dember et al., 
1996).  
The 3’(-)SL is thought to function as the promoter for the initiation of plus-strand 
RNA from the minus strand RNA template. In this study, evidence was obtained 
indicating that the mapped TIA-1/TIAR binding sites function as cis-acting sequences for 
plus-strand synthesis. In gel mobility shift assays elimination of the L1 and L2 AU nt in 
the WNV3’(-)SL RNA by deletion or substitution with Cs reduced in vitro binding of 
TIA-1/TIAR to barely detectable levels. The binding activity of TIA-1 and TIAR was 
resumed with sequential restoration of A or U nt in p∆L1 plus ∆L2 mutant RNA. For 
example, in mutant RNAs that have L1 deleted with one U, two Us, three AU, four AU, 
and five AU nt sequentially restored in L2, the binding activity of rTIAR (60 nM) 
sequentially increased 0.7, 1, 4.5, 8, and 14% than that of p∆L1,∆L2 mutant RNA, 
respectively. The results obtained from the in vitro gel mobility shift assays of           
TIA-1/TIAR with various WNV3’(-)SL mutant RNA probes correlated very well to the 
effect on virus growth when these mutations/deletions were introduced into a WNV 
infectious clone. Deletion or C substitution of the entire AU-rich sequence in either L1 or 
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L2 was lethal. Deletion of a single U from either loop or 2 Us in L2 that left the wildtype 
UUAAU in one loop and 3 or 4 AU nt in the other loop, produced viable virus with 
wildtype plaque phenotype. When the L1 AU sequences were shortened to 2 AU nt in 
mutant L1∆U19U20, no plaques were detected on the transfection plates but after one 
passage a second site mutation (RG21) occurred at G21 so that after structural 
rearrangement 3 sequential As were present in L1. Similarly, when L2 contained only 
one U nt in mutant L2∆UAAUU, no plaques were detected on the transfection plate, 
however, a second site mutation (RG24) occurred in G24 leading to a structural 
rearrangement of 3 AU nt in L1 and 3 sequential Us in L2. Although both RG21 and 
RG24 were viable, these second site mutations produced virus with different plaque 
phenotypes. Like other mutant RNAs that left the wildtype UUAAU in one loop and 3 or 
4 AU nt in the other loop, RG21 that contained 4 nt (5’UAAA3’) in L1 and the wildtype 
sequence (5’UUAAU3’) in L2 produced virus with wildtype plaque phenotype. In 
contrast, RG24 that contained a shorter L1 with 3 nt (5’UAA3’) and a shorter L2 that 
contained only 3 U nt (5’UUU3’) produced virus with pinpoint plaque phenotype. A 
single nt substitution to a C in either L1 or L2 leaving the wildtype UUAAU in one loop 
and only two adjacent UU or two adjacent AU in the other loop also produces a viable 
virus with a pinpoint plaque phenotype. A low but detectable TIA-1 and TIAR binding 
activity was observed for these mutant RNAs in in vitro gel mobility shift assays. In 
contrast, a single nt substitution with a C in either loop that left the wildtype UUAAU in 
one loop and 3 or 4 adjacent AU nt in the other loop, produced viable virus with larger 
plaque phenotype. These data suggest that as TIA-1 and TIAR binding efficiency to the 
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WNV3’(-) SL RNA decreases, the size of the plaque produced also decreases. A 
previous study on the RNA binding protein, U1A, suggested that the flexibility of an 
RNA loop as well as the placement of positively charged protein residues were important 
for facilitating the initial interaction of an RNA with a protein by allowing the correct 
orientation of the RNA backbone within the protein RNA binding site (Katsamba, 
Myszka, and Laird-Offringa, 2001). It is possible that the lower number of A/U nt in 
either L1 and L2 in mutant RNAs that produced virus with pinpoint plaques interfere 
with the flexibility and/or the correct orientation of L1 and/or L2 to be compatible with 
the RNA binding site and thus reduce the efficiency of TIA-1 and/or TIAR binding.  
The minimal binding activity of TIA-1 and TIAR to the WNV3’(-)SL RNA mutants 
consistently correlated with the undetectable intracellular viral genomic and minus-strand 
RNA synthesis detected when cells were transfected with a WNV infectious clone RNA 
with the same mutations. When no intracellular viral genomic or minus-strand RNA was 
detected, no virus production was also observed. In contrast, mutant L1A18→C, which 
produced a pin point plaque phenotype and bound to TIA-1 and TIAR with a lower 
efficiency than did the wildtype RNA (data not shown) produced levels of intracellular 
viral genomic RNA that were 30 fold lower than those produced by the wildtype 
infectious clone. This mutant RNA produced levels of minus-strand RNA, which are only 
4 fold lower than that of the wildtype RNA. The results suggest that TIA-1 and/or TIAR 
may function as transcription factors for the initiation of WNV plus-strand RNA 
synthesis. The WNV3’(-)SL RNA-TIA-1/TIAR protein interactions might aid the viral 
replication complex in recognizing the 3’end of the minus strand template and/or assist 
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in the formation or stabilization of the 3’ terminal minus SL. For poliovirus, another 
plus-strand RNA virus, interactions between several cellular proteins and the terminal 3’ 
cloverleaf structure of the minus-strand RNA have also been postulated to be important 
for the initiation of genomic RNA synthesis. (Brunner et al., 2005; Roehl and Semler, 
1995).  
A type I cap is added to the 5’ end of the WNV genome. Cap methylation must 
occur before a cap can function in promoting translation (Muthukrishnan et al., 1975). 
The C-terminal portion of WNV NS5 is the RNA dependent RNA polymerase (RdRp), 
while the N-terminal part is a methyltransferase (Koonin, 1993). A recent mutational 
analysis of the terminal 74 nt WNV5’(+)SL structure showed that substitution of the 
sequences complementary to the L1 and L2 sequences ,which were designated Hd and 
Lb, had no effect on cap N-7 methylation by NS5 (Dong et al., 2007), indicating that 
these AU sequences were not necessary for capping of the genomic RNA. In contrast, the 
second and third nt of the viral genome as well as the bottom two helices of the 
WNV5’(+)SL RNA structure, which were designated Ha and Hb, were found to be 
required for N-7 methylation. Also, a minimum sequence of 20 nt in the 5’(+)SL that 
includes the first and the second nt was essential for 2’-OH ribose methylation (Dong et 
al., 2007). In the present study, the effect of all the mutations/deletions introduced into a 
WNV infectious clone on the predicted secondary structure of WNV5’(+)SL RNA were 
analyzed (data not shown). None of these mutations/deletions change any of the critical 
elements shown to be important for capping by either N-7 methylation or 2’-OH ribose 
methylation by NS5 (Dong et al., 2007), however, some of them contained a shorter or 
  
72
single-stranded Hd. These mutations/deletions that showed changes in Hd did not have 
consistent plaque phenotype but rather different phenotypes that varies from lethal to 
pinpoint or wildtype plaques. These data suggest that mutations/deletions introduced into 
the complementary WNV5’(+)SL RNA do not correlate with the viral phenotype 
observed. The complementary AU L1 and L2 sequences within the WNV5’(+)SL RNA 
are double-stranded and so do not provide binding sites for TIA-1/TIAR as demonstrated 
with mutant L1U19→C and MS2 RNAs, which both had the L1 and L2 AU sequences in 
a double stranded context. Although, none of the deletions or mutations introduced into 
L1 and L2 in the 3’(-)SL RNA had any effect on the translation of the genomic RNA 
when the initial input RNA  is capped in vitro, its not possible to rule out the possibility 
that if some of these mutations that affect WNV5’(+)SL RNA structure might also affect 
capping of the nascent RNA genomic RNA synthesized in infected cells. 
 
MATERIALS AND METHODS 
Cells. 
 Baby hamster kidney (BHK) 21, strain W12, cells (Vaheri et al., 1965) were 
maintained at 37oC in a CO2 incubator in Minimal Essential Medium (MEM) 
supplemented with 5% fetal bovine serum (FBS) (Atlas) and 10 µg/ml of gentamicin 
(Invitrogen).   
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Cloning, expression, and purification of recombinant TIA-1 and TIAR from E. coli.  
The cDNAs of the isoforms TIA-1b and TIARa were amplified from total RNA 
extracted from C3H/He mouse embryo fibroblasts by RT-PCR, cloned into the TA 
cloning vector pCR 2.1 (Invitrogen) and then subcloned into pCRT7/CT-TOPO 
(Invitrogen) to generate the expression vectors pTIA-1b and pTIARa. The expressed 
proteins contained a C-terminal (His)-tag. All inserts were verified by restriction and 
sequence analysis. Recombinant TIA-1 and TIAR proteins were expressed in E. coli 
Rosetta (DE3) pLysS cells (Novagen) as follows. Cells were transformed with plasmid 
DNA (10 ng) and grown in LB media containing carbenicillin (50 µg/µl) and 
chloramphenicol (34 µg/µl) to an OD600 of 0.6 at 37oC. Protein expression was induced 
by the addition of 0.05 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for 5 hr with 
continuous shaking at 37oC. To purify proteins to near homogeneity, cell pellets from a 
0.5 liter culture were resuspended in 1X Extraction/Wash Buffer (50 mM sodium 
phosphate, 300 mM NaCl2, PH 7.0) containing protease inhibitor cocktail (Complete 
Mini, EDTA free, Roche) and then lysed with a SLM-Aminco French pressure cell press 
(Heinemann) at 20,000 psi. Clarified supernatants were loaded onto cobalt columns 
(Talon metal affinity resin, Clontech), the columns were washed with 1X 
Extraction/Wash Buffer containing 15 mM imidazole, and the bound proteins were eluted 
with 1X Extraction/Wash Buffer containing 150 mM imidazole. The eluted protein 
fractions were combined, dialyzed against Storage buffer (20 mM sodium phosphate, 30 
mM KCl, 1 mM MgCl2, 0.5 mM EDTA, and 15% Ficoll 400), aliquoted, and stored at -
80oC. The protein concentration was measured using a Coomassie Plus Protein Assay 
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Reagent kit (Pierce) with a bovine serum albumin (BSA) protein standard. Proteins in 
eluted fractions were analyzed by 10% SDS-PAGE and detected by Coomassie blue 
staining.  
 
DNA constructs used as templates for RNA synthesis. 
 The construction of a plasmid containing the first 75 nts of the WNV5’ NCR 
(p5’NCR) was previously described (Shi, Li, and Brinton, 1996). This plasmid was 
amplified by PCR to provide the DNA templates used for in vitro transcription of the 
WNV3’(-)SL and WNV5’(+)SL RNAs. Mutant constructs were generated using the 
Quick-Change Site-Directed Mutagenesis kit (Stratagene) according to the 
manufacturer’s protocol. The sequences of the primers used to introduce mutations are 
available upon request. DNA extracted from selected positive colonies was sequenced to 
confirm the presence of the introduced mutations and/or deletions. pWNV-Trun 
(Elghonemy, Davis, and Brinton, 2005) was used to amplify DNA templates for the in 
vitro synthesis of the 3’terminal 89 nts of the WNV genome.  
 
In vitro transcription of 32P-labelled and unlabeled RNA.  
WNV3’(-) SL RNA, WNV3’(+)SL RNA,  WNV5’(+)SL RNA, and a number of 
WNV3’(-)SL mutant RNAs were in vitro transcribed using a MAXIscript in vitro 
transcription kit (Ambion) in 20 µl reactions that contained T7 RNA polymerase (30 U), 
a  Qiaquick Gel Extraction kit (Qiagen)-purified PCR product (1 µg), 0.8 mM [α-32P] 
GTP (3000 Ci/mmol, 10 mCi/ml; Amersham Biosciences), 3 µM GTP and 0.5 mM CTP, 
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UTP, and ATP. The in vitro transcription mixture was incubated at 37oC for 2 hrs and 
transcription was stopped by addition of DNase I (1U) for 15 min at 37oC. After addition 
of an equal volume of 1X Gel Loading Buffer II (Ambion), the reaction mixture was 
heated at 95oC for 5 min. RNA transcripts were purified by electrophoresis on a 6 % 
PAG containing 7 M urea. The wet gel was autoradiographed and the 32P-labelled RNA 
band was excised. RNA was eluted from the gel slices by rocking overnight at 4oC in 
Elution Buffer (0.5 M NH4OAC, 1 mM EDTA, and 0.1 % SDS). The eluted RNA was 
filtered through a 0.45 µm cellulose acetate filter unit (Millipore) to remove gel pieces, 
precipitated with ethanol, resuspended in water, aliquoted, and stored at -80oC. The 
amount of radioactivity incorporated into each RNA probe was measured with a 
scintillation counter (Beckman LS6500) and the specific activity [calculated as described 
previously, (Blackwell and Brinton, 1997)] was routinely about 1.3 X 107 cpm/µg. 
Unlabeled viral RNA was in vitro transcribed as described above except that 1 mM of 
each NTP was added to the reaction mixture. After synthesis, these RNAs were purified 
on NucAway spin columns (Ambion) and RNA concentrations were calculated based on 
the UV absorbance measured at 260 nm. 
 
Transfection of in vitro transcribed full-length WNV genomic RNA. 
 The infectious clone used in this study is a chimera composed of the lineage I WNV, 
strain Eg101, and the lineage II WNV, strain 956 D 117 3B, sequences cloned into 
pBR322 under the control of an SP6 promoter (Yamshchikov et al., 2001). Genomic 
RNA was synthesized, gel purified, and XBaI linearized from WNV infectious clone 
  
76
DNA (1 µg) using a Message Maker kit (Epicenter) and SP6 RNA polymerase. BHK 
cells were seeded in six well plates (2 x 105 cells per well) and grown to ~ 90% 
confluency. The cells were washed and then transfected with 100 ng of infectious clone 
RNA using a mixture of OPTI-MEM (Invitrogen) and DMRIE-C (Invitrogen). After 3 
hours of incubation at 37oC in 5% CO2, the transfection medium was removed and 
replaced with either fresh MEM containing 5% FCS or MEM containing 0.5% SeaKem 
ME agarose (BioWhittaker Molecular Applications) and 2.5% FCS. Three serial passages 
were done in duplicate by transfer of 100 µl of media harvested at 72 h after 
transfection/infection to a fresh well in a 6 well plate. Plaque titration was done as 
previously described (Elghonemy, Davis, and Brinton, 2005). 
 
Site directed mutagenesis of the infectious clone.  
The strategy for inserting mutations into the WNV infectious clone, which utilizes a 
shuttle vector containing the ligated 3’ and 5’ regions of the WNV genome sequence, 
was described previously (Elghonemy, Davis, and Brinton, 2005). Mutations and 
deletions in the first 75 nt of the WNV3’(-)SL RNA in the shuttle vector DNA were 
introduced using a Quick-Change Site Directed Mutagenesis kit (Stratagene), according 
to the manufacturer’s protocol. The sequence of the mutant shuttle vectors as well as of 
the appropriate regions of the final mutated infectious clone DNAs were checked by 
DNA sequencing. The primers used for site-directed mutagenesis and RNA synthesis are 
available upon request. 
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Gel mobility shift assays. 
 32P-labelled WNV3’(-)SL RNA probe diluted in Binding Buffer (20 mM sodium 
phosphate, 30 mM KCl, 1 mM MgCl2, 0.5 mM EDTA, 3% Ficoll 400, and 10 U RNasin) 
was denatured at 85oC for 10 min and slowly renatured (0.1oC/sec) to 20oC. Reaction 
mixtures containing the RNA probe (2000 cpm; 0.2 nM) and different concentrations of 
rTIA-1 (50-900 nM) or rTIAR (5-90 nM) in a final volume of 10 µl of Binding Buffer 
plus 10 nM of the nonspecific competitor tRNA were incubated at room temperature for 
30 min and the RNA-protein complexes formed were electrophoresed on a 5% non-
denaturing PAG at 100 V/hr in 0.5X TBE at 4oC. Gels were dried and visualized by 
autoradiography. For competition gel-shift assays, purified rTIA-1 (600 nM) and purified 
rTIAR (60 nM) were incubated with increasing concentrations of one of the nonspecific 
competitors, poly I/C (0.1–1 ng) or tRNA (2.5-20 nM) or with the specific competitor, 
unlabeled WNV3’(-)SL RNA (0.2-5 nM) for 10 min prior to the addition of 0.2 nM 
(2000 cpm) of the 32P-labelled RNA probe. The binding activity of each mutant RNA 
probe was compared to that of the wildtype WNV3’(-)SL RNA probe. The signal 
intensities of the RNA protein complex and free probe gel bands were quantitated using a 
Bio-Imaging Analyzer PhosphorImager (Molecular Dynamics). The amount of RNA 
protein complex was divided by the amount of free probe to determine the percent RNA 
probe shifted, which was plotted against the rTIA-1 or rTIAR protein concentration used 
in the reaction. Data points graphed were the average of three replicate binding 
experiments. Standard deviation of the mean was calculated using the ESTDEV method 
in Microsoft Excel.   
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Quantitative Real-time RT-PCR of the intracellular viral RNA.  
Confluent BHK monolayers in 6 well plates were transfected with 200 ng of wildtype 
or mutated WNV infectious clone RNAs as described above. Total cell RNA was 
extracted at different times post transfection using TRI Reagent (Molecular Research 
Center, Inc.) according to the manufacture’s protocol. The intracellular viral genomic 
RNA was relatively quantified on an Applied Biosystems 7500 real-time PCR system 
using the TaqMan one-step RT-PCR kit according to the supplier’s instructions. The 
amplification primer-probe set used targeted the NS1 region and consisted of the forward 
primer 5’-GGCGGTTCTAGGAGAAGTCA-3’, the reverse primer 5’-
CTCCTGTTGTGGTTGCTTCT-3’, and the TaqMan probe 5’-6Fam-
TGCACCTGGCCAGAAACCCACACTCTGT-TAMRA-3’. For minus-strand RNA 
specific detection, T7-tagged primer real-time RT-PCR was done as previously described 
(Lanford et al., 1994; Samuel and Diamond, 2005). Briefly, a TaqMan one-step RT-PCR 
reaction mixture containing 800 ng of total cell RNA and 2 pmol of the T7 tagged minus-
strand primer (5’GCGTAATACGACTCACTATAGAGGGCGGTTCTAGGAGAAG 
T-3’; the bold sequence is the T7 tag sequence and the rest of the sequence is from the 
WNV NS1 region) was incubated for 30 min at 50oC for reverse transcription and then at 
95oC for 30 min to inactivate the reverse transcriptase enzyme. Following the inactivation 
step, 20 pmol of the T7 primer (5’-GCGTAATACGACTCACTATA-3’), 20 pmol of 
the specific minus-strand primer (5’-CTCCTGTTGTGGTTGCTTC-3’), and 5 pmol of 
the TaqMan probe were added and the reaction was subjected to 40 cycles at 95oC for 15 
sec and then 60oC for 1 min. Both plus-strand RNA and minus-strand RNA were 
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normalized using GADPH mRNA detected with the TaqMan Rodent GADPH control kit 
(Applied Biosystems). The plus- or minus-strand RNA levels were also calibrated to the 
amount of input viral RNA detected at 6 or 2 hr post transfection, respectively. The 
relative quantification units of RNA were determined as described previously (Scherbik 
et al., 2006). 
 
Detection of intracellular viral antigen.  
BHK cells (2 x 103) were seeded onto 3 mm coverslips and 24 hr later were 
transfected with 100 ng of WNV infectious clone RNA. Three hours after transfection, 
cells were fixed in 4% paraformaldehyde and then permeabilized using 100% chilled 
methanol. The cells were washed several times in PBS and incubated with anti-WNV 
hyperimmune serum (kindly provided from Robert B. Tesh, University of Texas) at a 
dilution of 1:100 for 1 hour at 37oC. The cells were then washed three times with cold 
PBS and incubated with anti-mouse immunoglobulin G antibody conjugated with 
Rhodamine (1:300) (Santa Cruz Biotechnology). Cell nuclei were stained with 0.5 µg/ml 
Hoechst 33258 (Molecular probes). After washing, cover slips were mounted in 
polyvinyl alcohol mounting medium with DABCO (Fluka) and the cells were viewed and 
photographed with a Zeiss Confocal Microscope LSM 510 (Zeiss, Germany) using 100X 
oil immersion objective with 1X zoom. The images were merged and analyzed using 
Zeiss software version 3.5.  
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RNA secondary structure prediction. 
 The secondary structure of each RNA probe used in this study was predicted using 
M-Fold, version 3.1 (Zuker, 2003 ).  
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CHAPTER III 
ADDITIONAL DATA 
 
Effect of substitution of L1, L2, or L3 with As or Us.  
Both TIA-1 and TIAR were previously reported to bind to poly(A) (Taupin et al., 
1995; Tian et al., 1991) and poly(U) (Kawakami et al., 1992; Taupin et al., 1995). 
Although both proteins have a higher binding affinity for poly(U) than for poly(A), TIA-
1 binds to poly(A) more efficiently than does TIAR (Kawakami et al., 1992; Taupin et 
al., 1995). To determine whether increasing the number of As in L1 and/or L2 
preferentially increased the binding activity of rTIA-1 for the WNV3’(-)SL RNA, the Us 
and Cs in L1, L2, and L3 were replaced with As separately or in combination and the 
mutant RNAs were tested in in vitro  binding assays with each of the proteins. 
Specifically, L1 (5’UAAUU3’) was replaced by 5’AAAAC3’ to form the L1→As 
mutant RNA. In this mutant, U20 was substituted with C to preserve the predicted RNA 
secondary structure. L2 and L3 were replaced separately with As to make RNA mutants 
L2→As and L3→As, respectively. The L1+L2→As mutant RNA had As in both L1 and 
L2. None of these mutations altered the predicted RNA secondary structure (Fig. 3.1A). 
With rTIAR, similar levels of binding were observed with the wild type, L1→As, 
L2→As, and L3→As RNAs (Fig. 3.1B lower panel, lanes 2-5, 7-10, 12-15, and 22-25 
and Fig. 3.1D), but increased binding activity was observed with the L1+L2→As RNA 
(Fig. 3.1B lower panel, lanes 17-20 and Fig. 3.1D). In contrast, all of these mutant RNAs 
bound more efficiently to rTIA-1 than did the wild type RNA. The L1+L2→As RNA 
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showed the most efficient binding, L2→As bound more efficiently than L1→As RNA 
and L3→As RNA bound more efficiently than either the L2→As or L1→As RNAs (Fig. 
3.1B upper panel and Fig. 3.1C).   
The nts in L1, L2, and L3 were next replaced with Us and the mutant RNAs were 
designated L1→Us, L2→Us, and L3→Us, respectively. The predicted RNA secondary 
structure was preserved in all of these mutant RNAs. Both proteins bound more 
efficiently to all of the U substitution RNAs than to the wild type RNA. L3→Us RNA 
gave the highest level of binding (Fig. 3.2B). Increases of 4, 11, and 19% in the binding 
activity of rTIAR (60 nM) were observed with the L1→Us, L2→Us, and L3→Us mutant 
RNAs, respectively, as compared to the wild type RNA (data not shown). The binding 
activity of rTIA-1 (600 nM) for the L1→Us, L2→Us, and L3→Us mutant RNAs was 10, 
23, and 35%, respectively, higher than that for the wild type RNA (data not shown). An 
additional RPC band that migrated slower than the RPC usually observed with the wild 
type RNA was observed in assays with either protein and the L3→Us RNA (Fig. 3.2B).  
These results indicate that substituting L1 or L2 with As did not alter TIAR binding 
activity but enhanced TIA-1 binding activity. However, the binding activity of both 
proteins increased when As were present in both L1 and L2 or when L1 or L2 consisted 
of single-stranded U tracts, but the binding of TIA-1 to U tracts was enhanced to a greater 
degree than that of TIAR. The increase in the binding efficiencies of both rTIA-1 and 
rTIAR observed for the L3→Us mutant RNA and the observation of an additional RPC 
band strongly suggested that the substitution of 9 Us in the terminal loop of the structure 
had created an additional binding site. 
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To further analyze this new binding site, deletions in L1 or L2 were made separately 
or in combination in the L3→Us mutant RNA (Fig. 3.2A). The binding activities of both 
recombinant proteins for the mutant RNAs L3→Us, p∆L1, L3→Us, ∆L2, and L3→Us, 
p∆L1,∆L2 progressively declined (Fig. 3.2B, Lanes 7-10, 12-15, and 17-21; Fig. 3.2C 
and D) as compared to those for the L3→Us RNA (Fig. 3.2B, Lanes 2-5; Fig. 3.2C and 
D). With both proteins, the percent decrease in binding when either L1 or L2 or both L1 
and L2 were deleted in the L3→Us RNA was similar to that observed when these loops 
were deleted in the wild type RNA (compare Fig. 3.2B, C, and D with Fig. 2.3B, C, and 
D). The additional RPC band that was observed with the L3→Us RNA was also observed 
when the L3→Us,∆L2, and L3→Us,p∆L1,∆L2 RNAs were used but was not observed 
with  L3→Us,p∆L1 RNA.  
 
Effect of increasing the distance between L1 and L2 on TIA-1 and TIAR binding 
activity. 
The mapping experiments described above indicated that both L1 and L2 are 
required for efficient TIA-1 or TIAR binding to the WNV3’(-)SL RNA. In the predicted 
secondary structure of the WNV3’(-)SL RNA, these two loops are separated by a 4 base 
pair stem (Fig.3.3A). To determine if the distance between L1 and L2 is important for 
efficient protein binding, four additional base pairs were inserted to increase the distance 
between the two loops (LS RNA). This mutation did not alter the overall predicted 
secondary structure of the WNV3’(-)SL RNA (Fig. 3.3A). The LS RNA probe bound 
significantly less efficiently to both proteins (Fig. 3.3B, lanes 7-10; Fig. 3.3C and D) than 
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Figure 3.1: Effect of A substitutions in L1, L2, and L3 within the WNV3’(-)SL RNA 
on rTIA-1 and rTIAR binding activity. (A) Predicted secondary structures of mutant 
RNAs. Mutations are indicated by asterisks. (B) Representative gel mobility shift assays 
with rTIA-1(upper panel) or rTIAR (lower panel) and each mutant RNA probe. (Lanes 1-
5) wild type RNA; (Lanes 6-10) L1→As RNA; (Lanes 11-15) L2→As RNA; (Lanes 16-
20) L1+L2→As RNA; and (Lanes 21-25) L3→As RNA. (C) and (D) Percent RNA probe 
shifted.   
 
Wt L1→As L2→As L1+L2→As L3→As
A.
B.
D.C.
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
A
A
U
C C UC
UU
A
C
A
A A
U
C
AU
CG
CG
AU
GU
CG
*
*
*
5’ 3’
. .. .
C
U
A
C
A
C
AU
AG
U
A
UA
UA
U
A GC
A
A
A
A A AA
AA
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
RPC
RPC
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A G
C
A
A
A
A A A A
AA
A
C
A
A A
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. . 5’ 3’. .. .
A
A
A
A
A
C
AA
AG
U
A
UA
UA
U
A G
C
A
A
U
C C U C
UU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
FP     50    300  600    800 nM FP    50   300  600  800  nM FP     50    300   600  800  nM FP     50    300  600   800 nM FP     50    300   600   800  nM
1    2    3     4    5 6    7    8    9   10 11  12   13   14  15 16  17   18  19  20 21   22   23   24   25
FP     10     20      60     90 nM FP   10      20     60      90  nM FP    10     20     60     90  nM FP     10      20    60     90   nM FP        10     20     60      90 nM
1     2     3    4     5 6    7    8      9    10 11  12   13  14   15 21  22   23  24   2516   17   18   19  20
C
U
A
C
A
C
AU
AG
UA
UA
UA
U
A GC
A
A
U
C C UC
UU
A
U
U
A U
U
C
AU
CG
CG
AU
GU
CG
5’ 3’
. .. .
20
40
60
L1
L2
L3
*
* ***
* *
*
* * **
* *
**
*
*
* **
TIA-1 TIA-1 TIA-1 TIA-1 TIA-1
TIAR TIAR TIAR TIAR TIAR
0
10
20
30
40
50
60
70
80
90
0 200 400 600 800
TIA-1 (nM)
Pe
rc
en
t o
f R
N
A
 p
ro
be
 sh
ift
ed
Wt
L1→As
L2→As
L1+L2→As
L3→As
0
10
20
30
40
50
60
70
80
90
0 20 40 60 80
TIAR (nM)
Pe
rc
en
t o
f R
N
A
 p
ro
be
 sh
ift
ed
Wt
L1→As
L2→As
L1+L2→As
L3→As
  
92
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Effect of deletions in L1 and/or L2 of the L3→Us mutant RNA on   
rTIA-1 and rTIAR binding activity. (A) Predicted secondary structures of the mutant 
RNAs. Deletions are indicated by wedges. (B) Representative gel mobility shift assays 
with rTIA-1(upper panel) or rTIAR (lower panel) and the WNV3’(-)SL or mutant RNA 
probes. (Lanes 1-5) L3→Us RNA; (Lanes 6-10) L3→Us,p∆L1; (Lanes 11-15) 
L3→Us,∆L2 RNA; (Lanes 16-20)  L3→Us, p∆L1,∆L2 RNA. (C) and (D) Percent RNA 
probe shifted.   
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Figure 3.3: Effect of increasing the distance between L1 and L2 within the  
WNV3’(-)SL RNA on rTIA-1 and rTIAR binding activity. (A) Predicted secondary 
structures of the LS mutant RNA. Mutations are indicated by asterisks. (B) 
Representative gel mobility shift assays with rTIA-1(upper panel) or rTIAR (lower panel) 
and the WNV3’(-)SL or LS RNA probes. (Lanes 1-5) wild type RNA; (Lanes 6-10) LS 
RNA. (C) and (D) Percent RNA probe shifted.   
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did the wild type RNA. The protein binding efficiency for the LS RNA was similar to 
that observed with RNAs that had either L1 or L2 deleted or mutated to Cs (compare Fig. 
3.3 with Fig. 2.2 and 2.3). These results indicated that the efficiency of protein binding 
was dependent on an optimal distance between L1 and L2.  
 
DISCUSSION  
A significant decrease in the binding of either TIA-1 or TIAR was observed when 
either L1 or L2, but not L3, was deleted. Although all these loops contains an AU stretch, 
L1 and L2 each contain a UAAUU sequence whereas L3 contains UAA. TIA-1 and 
TIAR each contain three adjacent RRMs. It is not known how many of the RRMs in a 
single protein molecule interact with an RNA molecule during efficient binding. The 
spatial orientation of multiple single-stranded binding sites presented on an RNA 
structure may determine how many of the RRMs contact the RNA. Evidence from the 
present study suggests that a protein molecule can simultaneously contact the L1 and L2 
AU sequences but not those in L3 in the WNV3’(-)SL RNA. The minimal binding site 
located at the 3’ end of L3 in the WNV3’(-)SL RNA may not be in an optimal 
orientation for protein binding or it may be located too far away from L2. L1 and L2 are 
separated by a 4 base pair stem, while L3 is separated from L2 by a 6 base pair stem. 
Increasing the distance between L1 and L2 by four additional base pairs, decreased the 
binding of either protein to levels similar to those obtained when L1 or L2 was deleted or 
mutated to Cs. The distance between L1 and L2 in this mutant was similar to that 
between L3 and L2 in the WNV3’(-)SL RNA. Also, the binding activity of either protein 
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was affected to a greater degree by deletion or mutation of L2 than by the same changes 
in L1. The larger size of L2 (9 nt) as compared to L1 (5 nt) may provide an increased 
flexibility that enhances the efficiency of protein interaction with the binding site. The 
significant increase in binding observed when the 9 nts of L3 were substituted with Us 
suggests that these 9 Us created one or possibly two, additional protein contact sites. This 
hypothesis is further supported by the observation of an additional RNA-protein complex 
band in the gel mobility shift assays done with either protein and the L3→Us probe and 
also by the ability of both proteins to bind efficiently to the L3→Us RNA in the absence 
of both L1 and L2 (Fig. 3.2). Recent structural analysis of RNA-protein complexes 
formed by polypyrimidine tract binding protein, a protein with four RNA binding 
domains (RBDs), showed that each of these four domains bound to separate pyrimidine 
tracts in the same pre-mRNA (Oberstrass et al., 2005). RRM2 of both TIA-1 and TIAR 
has been shown to account for the majority of the binding activity for short U-rich RNAs, 
but the binding affinity of both proteins increased when either of the other two RRMs 
were present (Dember et al., 1996). An alternative possibility is that two TIA-1 or TIAR 
molecules bind to one WNV3’(-)SL RNA. In the present study, this appeared to occur 
only when L3 was mutated to Us.  
In the initial study, TIA-1 was not detected among the bound proteins eluted from an 
WNV3’(-)SL RNA affinity column (Li et al., 2002) and subsequent gel mobility shift 
assays showed that TIA-1 binds to this RNA 10 times less efficiently than does TIAR. 
The 10 fold higher binding efficiency of TIAR for the WNV3’(-)SL RNA suggests that 
TIAR would out-compete TIA-1 for binding to the WNV3’(-)SL RNA except when 
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TIAR concentrations are low. It is possible that other AU-rich sequence binding proteins 
may also be able to interact with the WNV3’(-)SL RNA. Translational regulation of 
some cell mRNAs has been previously reported to be combinatorially regulated by 
multimeric protein complexes that contain TIA-1 and/or TIAR and different 
combinations of other ARE-binding proteins including FUSE-binding proteins (FBPs) 
(Rothe et al., 2006), HuR proteins (Kawai et al., 2006), HuR and AU-binding factor 1 
(AUF1) (Cok et al., 2004), or tristetraprolin (TTP) (Zhang et al., 2002). The AU 
sequences in the mRNA 3’UTRs binding to these complexes contain multiple, 
redundant, and/or long AU tracts and it is currently not known how protein binding 
specificity is determined or whether multiple proteins compete for the same binding sites. 
It is expected that not only the presence and location of specific binding sites in the RNA 
but also the conformation of the RNA would play important roles in determining the 
binding affinities of the various ARE-binding proteins that form a complex with a 
particular 3’UTRs. Protein-protein interactions also appear to play a role in the 
formation of these complexes (Katsanou et al., 2005).  
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CHAPTER IV 
Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected 
cells interferes with SG formation and PB assembly. 
 
ABSTRACT 
The West Nile virus minus-strand 3’ terminal stem loop (SL) RNA was previously 
shown to bind specifically to cellular stress granule (SG) components, T-cell intracellular 
antigen-1 (TIA-1) and the related protein TIAR. In vitro TIAR binding was 10 times 
more efficient than TIA-1. The 3’(-)SL functions as the promoter for genomic RNA 
synthesis. Colocalization of TIAR and TIA-1 with the viral replication complex 
components, dsRNA and NS3, was observed in the perinuclear regions of WNV and 
dengue virus infected cells. The kinetics of accumulation of TIAR in the perinuclear 
region was similar to those of genomic RNA synthesis. In contrast, relocation of TIA-1 to 
the perinuclear region began only after maximal levels of RNA synthesis had been 
achieved except when TIAR was absent. Virus infection did not induce stress granules 
and progressive resistance to SG induction by arsenite developed coincident with TIAR 
relocation. A progressive decrease in the number of Processing Bodies (PB) was also 
observed in infected cells. These data suggest that the interaction of TIAR with viral 
components facilitates flavivirus genome RNA synthesis and inhibits SG formation 
which prevents the shutoff of host translation.  
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INTRODUCTION 
Eukaryotic cells respond to environmental stresses, such as oxidative stress, heat 
shock, UV irradiation, and endoplasmic reticulum (ER) stress, and some viral infections, 
by altering the protein expression machinery (Kedersha and Anderson, 2002). The 
expression of proteins responsible for damage repair is increased, whereas translation of 
constitutively expressed proteins is aborted via redirection of these mRNAs from 
polysomes to discrete cytoplasmic foci known as stress granules (SG) for transient 
storage (Kedersha et al., 1999). Several cell proteins, including T cell intracellular 
antigen-1 (TIA-1), TIA-1 related protein (TIAR) (Kedersha et al., 1999), and Ras-Gap-
SH3 domain-binding protein (G3BP) are involved in SG assembly (Tourriere et al., 
2003). Phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) by protein 
kinase R (PKR) and other kinases prevents the assembly of the active ternary 
preinitiation complex eIF2-GTP-tRNAMet and inhibits translation initiation and polysome 
assembly (Anderson and Kedersha, 2006). TIA-1 and TIAR bind to these inactive 
translation initiation complexes as well as to poly(A)+ of cell mRNAs and self-aggregate 
promoting the assembly of SG (Kedersha et al., 1999). Processing Bodies (PB), another 
type of foci identified in the cytoplasm of eukaryotic cells (Eulalio, Behm-Ansmant, and 
Izaurralde, 2007), contain components of the 5’-3’ mRNA degradation pathway as well 
as the miRNA-dependent silencing protein GW182 (Eystathioy et al., 2002). PB do not 
require eIF2α phosphorylation for their assembly (Kedersha et al., 2005). Although SG 
and PB differ in their size and shape as well as in their mechanism of assembly, the two 
types of foci are found side by side in mammalian cells and a physical association 
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between them was previously demonstrated by real-time fluorescence imaging (Kedersha 
et al., 2005). This study also showed that PB are highly motile whereas the positions of 
SG are relatively fixed and that SG deliver mRNAs to associated PB for degradation. 
TIA-1 and TIAR are essential, multifunctional, nucleocytoplasmic shuttling proteins 
that are expressed in most types of cells and tissues (Beck et al., 1996; Jin et al., 2000). 
TIA-1 and TIAR contain three N-terminal RNA recognition motifs (RRM) (Anderson, 
1995) and a glutamine-rich C-terminal domain, called prion related domain (PRD), that 
shares structural and functional characteristics with the aggregation domains of 
mammalian and yeast prion proteins (Gilks et al., 2004). A recombinant TIA-1 protein 
lacking the three RNA binding domains was unable to bind poly(A)+ RNA and recruit it 
to SG (Kedersha et al., 1999). Deletion of the TIA-1 PRD inhibited protein aggregation 
and SG assembly (Gilks et al., 2004). PRD aggregation is regulated by the molecular 
chaperone heat shock protein 70 (HSP70) and over expression of HSP70 prevented 
cytosolic aggregation of PRD (Gilks et al., 2004). TIA-1 and TIAR also regulate 
translational silencing of a subset of cellular mRNAs via binding to AU-rich sequences in 
the 3’ noncoding regions (NCRs) of these mRNAs (Anderson and Kedersha, 2002b). In 
addition, TIA-1 and TIAR proteins interact specifically with the 3’-terminal stem loop 
structure of the West Nile virus minus-strand RNA [WNV3’(-)SL] (Li et al., 2002).  
WNV is classified in the family Flaviviridae, genus Flavivirus, along with a number 
of other human pathogens including dengue virus (DV), Japanese encephalitis virus, 
yellow fever virus, and tick-borne encephalitis virus. The flavivirus genome is a single-
stranded, positive sense RNA of ~11 Kb containing a single open reading frame and is 
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the only viral mRNA produced during the virus replication cycle. Flavivirus replication 
takes place in the perinuclear region of the cytoplasm of infected cells. Three structural 
(capsid, membrane, and envelope) and seven non-structural (NS1, NS2a, NS2b, NS3, 
NS4a, NS4b, and NS5) viral proteins are produced via proteolytic processing of the 
single polyprotein by viral and cellular proteases (Brinton, 2002; Lindenbach and Rice, 
2007). The C-terminal portion of NS5 is the RNA dependent RNA polymerase (RdRp), 
while the N-terminal part is a methyltransferase involved in RNA capping (Koonin, 
1993). The N-terminus of NS3 has serine protease activity, while the C-terminus contains 
helicase, NTPase, and triphosphatase activities (Brinton, 2002; Lindenbach and Rice, 
2007). The NS3, NS5, and NS1 proteins as well as the hydrophobic NS2a, NS2b, NS4a, 
and NS4b proteins were previously shown to be components of membrane bound viral 
RNA replication complexes located in the perinuclear region of infected cells (Kapoor et 
al., 1995; Uchil and Satchidanandam, 2003; Vasudevan et al., 2001).  
In this study, both TIA-1 and TIAR were shown to colocalize with the WNV and DV 
NS3 protein as well as with viral dsRNA, a marker for viral replication complexes, in 
infected mammalian cells. The data obtained suggest that these interactions facilitate viral 
genomic RNA synthesis and downregulate SG formation in infected cells.  
 
RESULTS 
 TIA-1 and TIAR colocalize with WNV and DV2 proteins in infected BHK cells.  
A previous study showed that in C57/BL/6 TIAR-/- mouse embryo fibroblasts 
(MEFs), the replication of WNV was reduced by 6- to 8-fold compared to control MEFs, 
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whereas WNV grew to the same levels in TIA-1-/- MEFs and control MEFs (Li et al., 
2002). This was consistent with the 10 fold higher binding efficiency of TIAR for the 
WNV3’(-)SL as compared to TIA-1 (Li et al., 2002). To determine whether a flavivirus 
infection altered the distribution of these cell proteins, BHK cells were infected with 
WNV at MOI of 5 and at 3, 6, 12, and 24 hpi, the cells were fixed, permeabilized, 
incubated with anti-TIA-1 or anti-TIAR and then anti-WNV antibody, and visualized by 
confocal microscopy as described in Materials and Methods. As expected, TIAR (Fig. 
4.1A, green) and TIA-1 (Fig. 4.1E, green) were evenly distributed throughout mock 
infected cells (Anderson and Kedersha, 2002a). Under these infection conditions, WNV 
proteins were detected in about 90% of the cells. WNV proteins were faintly detected by 
6 hpi (Fig. 4.1B, red). Although at 6 hpi, TIAR was still found in both the cytoplasm and 
nucleus, this protein was also concentrated in a few bright foci in the cytoplasm (Fig. 
4.1B, green). Merged images obtained at 6 hpi showed colocalization of TIAR foci with 
foci of viral protein (Fig. 4.1B, merge). Foci of TIA-1 were not observed at this time 
(data not shown). By 12 hpi, the majority of TIAR was in the cytoplasm (Fig. 4.1C, 
green) and the amount of WNV protein had increased and was concentrated in the 
perinuclear region (Fig. 4.1C, red). Again, colocalization of TIAR but not TIA-1 (data 
not shown) with the viral proteins was observed mainly in perinuclear foci (Fig. 4.1C, 
merge). By 24 hpi, the intensity of WNV protein staining had increased significantly 
(Fig. 4.1D and F, red) and TIAR strongly colocalized in the perinuclear region with the 
WNV proteins (Fig. 4.1D, merge). In contrast, only a few bright cytoplasmic foci of TIA-
1 colocalized with the WNV proteins by 24 hpi (Fig. 4.1F, merge; a pattern similar to that 
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seen at 6 hpi with TIAR). Strong colocalization of TIA-1 with the WNV proteins was 
observed by 36 hpi (Fig. 4.1G, merge). Quantification of the amount of TIAR or TIA-1 in 
the nucleus confirmed that the distribution of both TIA-1 and TIAR was altered with time 
after WNV infection but the redistribution of TIAR occurred more rapidly (Fig. 4.1H). 
It was previously reported that the expression of TIA-1 was three times higher in 
TIAR-/- than in wildtype MEFs (Li et al., 2002). To determine if the time course of TIA-
1 redistribution was altered when TIAR was not present, TIAR-/- MEFs were infected 
with WNV (MOI of 5) and the locations of TIA-1 and WNV proteins were analyzed at 12 
and 24 hpi. TIA-1 was equally distributed in both the cytoplasm and nucleus of mock 
infected TIAR-/- MEFs (Fig. 4.2A, green], but these cells were significantly larger than 
BHK cells. The time course of appearance, staining intensity, and distribution of the 
WNV proteins in these cells (Fig. 4.2B and C, red) were similar to those observed with 
infected BHK cells. At 12 hpi, a few bright foci of TIA-1 that colocalized with WNV 
proteins were observed (Fig. 4.2B, merge), similar to what was observed by 12 hpi for 
TIAR in BHK cells. By 24 hpi, a significant increase in TIA-1 in the perinuclear region 
and strong colocalization with viral proteins was observed (Fig. 4.2C). At all times, a 
significant portion of TIA-1 remained in the nucleus. These results indicate that in the 
absence of TIAR, colocalization of TIA-1 with the viral proteins occurred more quickly 
with a time course similar to that of TIAR colocalization in cells expressing both 
proteins. 
To determine whether TIA-1/TIAR colocalization with viral proteins was also 
characteristic of other flavivirus infections, BHK cells were infected with DV2, (MOI of  
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Figure 4.1. Colocalization of TIA-1 and TIAR with WNV proteins in infected BHK 
cells. Laser scanning confocal microscopy of (A) mock infected or (B-D) WNV infected 
(MOI of 5) BHK cells stained with anti-WNV (red) and anti-TIAR antibody (green) at 
the indicated times post infection. (E, F, and G) BHK stained with anti-WNV (red) and 
anti-TIA-1 antibody (green) at the indicated times after WNV (F and G) or mock (E) 
infection. Nuclear DNA (blue) was stained with Hoechst 33258 dye. (H) Quantification 
of the amount of TIAR (left panel) or  TIA-1 (right panel) in the nucleus of mock-
infected cells (M) and WNV-infected cells at the indicated times after infection. The 
relative pixel intensity in the nuclei of 20 cells at each time after infection was measured 
and the mean values were plotted. Error bars indicate the standard deviation of the mean. 
Bar = 10µm. 
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Figure 4.2. Colocalization of TIA-1 with WNV proteins in infected TIAR-/- MEFs. 
Laser scanning confocal microscopy of (A) mock infected or (B-C) WNV infected (MOI 
of 5)  TIAR-/- MEFs stained with anti-WNV (red) and anti-TIA-1 antibody (green) at the 
indicated times post infection. Bar = 10µm. 
 
 
12 hpi
24 hpi
24 hpi
anti-WNV anti-TIA-1 Merge
B
C
A
M
oc
k-
in
fe
ct
ed
W
N
V
-in
fe
ct
ed
10 µm
  
107
0.1), a divergent flavivirus from a different serocomplex than WNV, and analyzed at 12, 
24, 36, and 72 hpi as described in Materials and Methods. Due to the lower MOI, at 12 
and 24 hpi, DV2 proteins were detected in only about 5% of the cells (data not shown). 
By 36 hpi, clusters of infected cells with bright virus-specific cytoplasmic foci were 
observed (~40% of the cells) (Fig. 4.3B and D, red). At 72 hpi, in about 60% of the cells, 
DV2 proteins were detected with a distribution and staining intensity (Fig. 4.3C and E, 
red) similar to that observed in WNV infected cells at 24 hpi (Fig. 4.1D and F, red). 
Strong colocalization of both TIAR (Fig. 4.3B and C, merge) and TIA-1 (Fig. 4.3D and 
E, merge) with DV2 proteins was detected at 36 and 72 hpi. This colocalization was 
primarily in the perinuclear region but was also observed in foci extending into the 
cytoplasm of the infected cells (Fig. 4.3B-E, merge). In the uninfected cells visible in the 
middle panels of Fig. 4.3B-E, TIA-1 and TIAR were equally distributed in the cytoplasm 
and nucleus. These results suggest that the colocalization of TIA-1/TIAR with viral 
proteins is a general feature of flavivirus infections. 
 
TIA-1 and TIAR interact with sites of WNV and DV2 RNA replication.  
In previous in vitro RNA-protein interaction assays, the TIA-1/TIAR proteins were 
shown to bind specifically to the WNV3’(-)SL RNA (Li et al., 2002). The minus-strand  
RNA of flaviviruses is present in infected cells only in RNA replication complexes 
(Brinton, 2002; Lindenbach and Rice, 2007). An antibody to dsRNA that does not detect 
either cellular ribosomal RNA or tRNA was previously utilized to detect flavivirus  
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Figure 4.3. Colocalization of TIA-1 and TIAR with DV2 proteins in infected BHK 
cells. (A) Mock infected or (B-E) DV2 infected (MOI of 0.1) BHK cells stained with 
anti-DV2 (red) and anti-TIAR (B and C, green) or anti-TIA-1 (D and E, green) antibodies 
at 36 and 72 hpi.  
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replication complexes in infected cells (Miller, Sparacio, and Bartenschlager, 2006). To 
test whether TIA-1/TIAR colocalized with viral dsRNA in infected cells, BHK cells 
infected with WNV (MOI of 0.1) or DV2 (MOI of 0.1) were fixed and incubated with 
anti-dsRNA and anti-TIA-1 or anti-TIAR antibody. A lower MOI for WNV and later 
time points were used to better visualize the replication complexes. Perinuclear foci 
stained with anti-dsRNA antibody were observed in WNV infected cells at 36 hpi (Fig. 
4.4B and C, red) but not in mock infected cells (Fig. 4.4A). In WNV infected cells, strong 
colocalization of TIA-1/TIAR with the dsRNA was observed in bright perinuclear foci 
(Fig. 4.4B and C, merge). Similar dsRNA perinuclear foci and similar TIA-1/TIAR 
colocalization with these foci were observed in DV2 infected cells at 72 hpi (Fig. 4.5B 
and C), indicating that TIA-1/TIAR strongly colocalized with flavivirus RNA complexes 
in infected cells.  
Previous immunofluorescence studies using antibodies specific to dsRNA as well as 
to individual flavivirus NS proteins suggested that NS3 and NS5 as well as NS1, NS2a, 
and NS4a associate with ds viral RNA in flavivirus replication complexes located in the 
perinuclear region of infected cells (Westaway et al., 1997; Westaway, Mackenzie, and 
Khromykh, 2003). Broader areas of colocalization were observed with the anti-WNV 
(Fig. 4.1) than with the anti-dsRNA antibody, suggesting that TIA-1/TIAR might also 
interact with a viral nonstructural protein. Coimmunoprecipitation experiments were done 
using lysates prepared from mock infected or WNV infected BHK cells at 24 hpi and 
anti-TIAR or anti-TIA-1 antibody as described in Materials and Methods. Cell lysates as 
well as immunoprecipitates were then analyzed by SDS-PAGE and transferred to 
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nitrocellulose membranes for Western blot analysis using anti-WNV (Fig. 4.4G, left 
panel). Four WNV proteins, presumed to be NS5, NS3, E, and NS1, were detected in 
lysates from WNV infected cells (Fig. 4.4G, left panel, lane 2), but not in lysates or 
immunoprecipitates from mock infected cells (Fig. 4.4G, left panel, lanes 1, 3, and 5). In 
immunoprecipitates from WNV infected cells, both anti-TIAR (Fig. 4.4G, left panel, lane 
4) and anti-TIA-1 (Fig. 4.4G, left panel, lane 6) antibody coimmunoprecipitated a viral 
protein with the expected size of NS3. To verify that this was NS3, samples precipitated 
with anti-TIA-1 or anti-TIAR antibodies was analyzed by Western blot analysis using an 
anti-WNV NS3 monoclonal antibody. NS3 was detected in lysates from WNV infected 
cells after immunoprecipitation with both anti-TIAR (Fig. 4.4G, right panel, lane 4) or 
anti-TIA-1 (Fig. 4.4G, right panel, lane 6) antibody.  
Anti-WNV NS3 monoclonal antibody was next used to study the colocalization of        
TIA-1/TIAR with NS3 in BHK cells infected with WNV or DV2 at 36 or 72 hpi, 
respectively. NS3 was previously shown to be broadly distributed around the nucleus and 
to colocalize with dsRNA foci in flavivirus-infected cells (Miller, Sparacio, and 
Bartenschlager, 2006). In the merged images, both TIA-1 and TIAR strongly colocalized 
with NS3 in WNV infected cells (Fig. 4.4E and F, merge). Bright focal areas as well as 
more diffuse areas of colocalization were observed. Similar results were observed in DV2 
infected cells at 72 hpi (Fig. 4.5E and F).  
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Figure 4.4. Interaction of TIA-1 and TIAR with WNV replication complex 
components. BHK cells were infected with WNV at a MOI of 0.1. Laser scanning 
confocal microscopy of (A and D) mock infected and WNV (B, C, E, and F) infected 
cells stained with anti-dsRNA (A-C, red) or anti-NS3 (D-F, red) and then with either anti-
TIAR (A, B, D, and E, green) or anti-TIA-1 (C and F, green) antibodies at 36 hpi. 
Enlarged views are included in the B and C merged panels. (G) Coimmunoprecipitation 
of WNV proteins by anti-TIA-1 and anti-TIAR antibodies. BHK cells were infected with 
WNV at a MOI of 5. Immunoprecipitates were visualized by Western blot using anti-
WNV (left panel) or anti-NS3 antibody (right panel). Lane 1, Mock infected lysate; Lane 
2, WNV infected lysate; Lanes 3 and 5, Mock infected immunoprecipitates; Lanes 4 and 
6, WNV infected immunoprecipitates. Arrows indicate the positions of the WNV proteins 
detected. Positions of molecular weight standards are indicated on the left. 
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Figure 4.5. Interaction of TIA-1 and TIAR with DV2 replication complex 
components. BHK cells were infected with DV2 (MOI of 0.1). Laser scanning confocal 
microscopy of (A and D) mock infected and DV2 infected (B, C, E, and F) cells stained 
with anti-dsRNA (A-C, red) or anti-NS3 (D-F, red) and then with anti-TIAR (A, B, D, 
and E, green) or anti-TIA-1 (C and F, green) antibodies at 72 hpi.  
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WNV and DV2 interfere with SG formation in infected BHK cells.  
TIA-1/TIAR were previously reported to be required for the formation of SG in cells 
after treatment with arsenite (Kedersha et al., 1999) and both proteins were shown to 
colocalize with viral nonstructural proteins and replication complexes in flavivirus 
infected cells. To determine whether a flavivirus infection would interfere with cellular 
SG formation, BHK cells were mock infected or infected with WNV and exposed to 
oxidative stress by treatment with 0.5 mM arsenite for 30 min. Infected cells were treated 
at 6, 12, or 24 hpi. The cells were then fixed and stained with anti-WNV (Fig. 4.6A-D, 
red) and anti-TIAR antibody (Fig. 4.6A-D, green). As described previously, at 6 hpi, only 
a small amount of colocalization of TIAR with WNV proteins was observed (Fig. 4.6B, 
merge). The number of SG induced by the arsenite was slightly reduced (Fig. 4.6B, 
green; Fig. 4.6E) as compared to mock infected cells (Fig. 4.6A, green; Fig. 4.6E). At 12 
hpi, SG formation further decreased (Fig. 4.6C, green; Fig 4.6E) as colocalization of 
TIAR and WNV proteins increased (Fig. 4.6C, merge). Few if any SG were detected at 
24 hpi (Fig. 4.6D, green; Fig 4.6E) in cells showing strong colocalization between TIAR 
and WNV proteins (Fig. 4.6D, merge). WNV infection alone did not induce SG 
formation at any time after infection (Fig. 4.1B-D, green). The effect of DV2 infection on 
SG formation was also investigated. BHK cells infected with DV2 for 36 or 72 hr were 
treated with 0.5 mM arsenite for 30 min and immunostained with anti-DV2 and anti-
TIAR (Fig. 4.7). At both times, strong colocalization of TIAR and DV2 proteins was 
observed. Few SGs was observed in infected cells (Fig. 4.7B and C, green; Fig. 4.7D), 
whereas many SG were observed in uninfected cells (Fig. 4.7A, green).  
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 Since phosphorylation of eIF2α at S51 also regulates SG formation, the effect of 
WNV and DV2 infections on eIF2α phosphorylation was assayed. BHK cells were 
infected with either virus and at various times after infection, cells were treated for 30 
min with 0.5 mM arsenite. Control infected cells were not treated with arsenite. Proteins 
in cell lysates were analyzed by Western blot using a polyclonal antibody specific for 
eIF2α phosphorylated at S51 (Fig. 4.6F). Under these experimental conditions, 
phosphorylation of eIF2α was not detected in mock infected cells or by 24 hr after WNV 
(Fig. 4.6F, lane 3) or 36 hr after DV2 (Fig. 4.7E, lane 1) infection. High levels of eIF2α 
phosphorylation were observed in extracts of mock infected cells treated with arsenite 
(Fig. 4.6F, lane 2). Reduced levels of phospho-eIF2α were detected in WNV infected 
extracts by 12 hpi and were further decreased by 24 hpi (Fig. 4.6F, lanes 4-6). In the DV2 
extracts, decreased phosphorylation of eIF2α was observed at later times post infection 
(Fig. 4.7E, lanes 2-5). The large number of uninfected cells present in the DV2 infected 
cultures are the source of the higher levels of phospho-eIF2α observed until 6 dpi. The 
levels of total eIF2α and of another protein involved in SG formation, G3BP, remained 
constant under all conditions tested and after infection with both viruses (Fig. 4.6F and 
4.7E). Although neither WNV nor DV2 infection induced SG formation in BHK cells, 
cells infected with both flaviviruses became progressively more resistant to SG induction 
by arsenite with time after infection. 
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Figure 4.6. WNV infection interferes with SG formation. Laser scanning confocal 
microscopy of mock infected (A) and WNV infected (MOI of 5) (B, C, and D) BHK cells 
treated with 0.5 mM arsenite for 30 min at the indicated times after infection. The cells 
were fixed, permeabilized, and stained with anti-WNV (A-D, red) and with the SG 
marker, anti-TIAR (A-D, green). Arrows indicate representative SG. (E) Quantification 
of the number of SG in mock-infected (M) cells and WNV-infected cells at the indicated 
times after infection. SG in 70 cells were counted for each experimental condition and the 
average number of SG/cell was plotted.  Error bars indicate the standard deviation of the 
mean. (F) Western blot analysis of phospho-eIF2α in BHK cells mock infected or 
infected with WNV (MOI of 5) and then treated or not treated with 0.5 mM of arsenite 
for 30 min at the indicated times after infection. Lane 1, Mock infected BHK cells; Lane 
2, cells treated with 0.5 mM arsenite for 30 min; Lane 3, cells infected with WNV; Lanes 
4-6, cells infected with WNV and then treated with arsenite for 30 min at the indicated 
times. Phospho-eIF2α (S51) (upper panel), total eIF2α (middle panel), and G3BP (lower 
panel) were detected with specific antibodies.  
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Figure 4.7. DV2 infection interferes with SG formation. Laser scanning confocal 
microscopy of mock infected (A) and DV2 infected (MOI of 0.1) (B and C) BHK cells 
treated with 0.5 mM arsenite for 30 min at the indicated times. The cells were fixed, 
permeabilized, and stained with anti-DV2 (A-C, red) and with the SG marker, anti-TIAR 
(A-C, green). Arrows indicate representative SG. (D) Quantification of SG in mock-
infected cells (M) and DV2-infected cells at different times after infection (36 and 72 
hpi). The number of SG in 70 cells for each experimental condition was counted and the 
average number of SG/cell was plotted.  Error bars indicate the standard deviation of the 
mean. (E) Western blot analysis of phospho-eIF2α in BHK cells mock infected or 
infected with DV2 and then treated or not treated with of arsenite for 30 min at various 
times after infection. Lane 1, cells infected with DV2 (MOI of 0.1); Lanes 2-5, cells 
infected with DV2 and then treated with arsenite at the indicated times post infection. 
Phospho-eIF2α (S51) (upper panel), total eIF2α (middle panel), and G3BP (lower panel) 
were detected with specific antibodies.   
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WNV and DV2 infections interfere with PB assembly.  
SG and PB share some components and are dynamically linked via their role in 
regulating cytoplasmic mRNA storage and/or degradation (Kedersha et al., 2005; 
Wilczynska et al., 2005). To test whether WNV and DV2 infections also interfere with 
PB assembly, BHK cells mock infected or infected with either WNV or DV2 were 
treated or not treated for 30 min with 0.5 mM arsenite at various times after infection. 
The cells were then fixed and incubated with antibody to the PB marker DCP1a and anti-
WNV (Fig. 4.8) or anti-DV2 (Fig. 4.9). PB were detected in untreated cells (Fig. 4.8A-C, 
green; Fig. 4.9A-C, green) as well as in arsenite treated cells (Fig. 4.8D-F, green; Fig. 
4.9D-F, green). In uninfected, WNV infected, and DV2 infected cells, PB were evenly 
distributed throughout the cytoplasm (Fig. 4.8 and Fig. 4.9). In both uninfected and 
infected cells treated with arsenite, the number of PB was decreased (Fig. 4.8 G; Fig. 
4.9G) and the remaining PB were mainly located around the nucleus (Fig. 4.8D-F, green; 
Fig. 4.9D-F, green). In WNV infected cells, a noticeable reduction in PB formation was 
observed by 24 hpi in untreated (Fig. 4.8B, green; Fig 4.8G, left panel) and arsenite-
treated (Fig. 4.8E, green; Fig 4.8G, right panel) cells as compared to mock infected cells 
(Fig. 4.8A and Fig. 4.8D, green; Fig 4.8G). A further reduction in PB formation was 
observed in both arsenite-untreated (Fig. 4.8C, green; Fig 4.8G, left panel) and treated 
(Fig. 4.8F, green; Fig 4.8G, right panel) WNV-infected cells at 36 hpi. In DV2 infected 
cells, a reduction in PB formation was observed at later times post infection (Fig. 4.9B, 
C, E, and F, green; Fig 4.9G) consistent with the slower replication kinetics of DV2.  
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Figure 4.8. WNV infection interferes with PB assembly. Laser scanning confocal 
microscopy of mock infected (A and D) and WNV infected (MOI of 5) (B, C, E, and F) 
cells that were treated (right) or not treated (left) with arsenite for 30 min at the indicated 
times. The cells were stained with anti-WNV (A-F, red) and then with anti-DCP1a (a PB 
marker) (A-F, green) antibody. Arrowheads indicate representative PB. (G) 
Quantification of the number of PB in mock-infected cells (M) and WNV-infected cells 
treated (right) or not treated (left) with arsenite. PB in 50 cells were counted for each 
experimental condition at the indicated times after infection and the average number of 
PB/cell was plotted. Error bars indicate the standard deviation of the mean.   
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Figure 4.9. DV2 infection interferes with PB assembly. Laser scanning confocal 
microscopy of mock infected (A and D) and DV2 infected (MOI of 0.1) (B, C, E, and F) 
cells that were not treated (A-C) or treated (D-F) with arsenite for 30 min at the indicated 
times after infection. The cells were then stained with anti-DV2 (A-F, red) and anti-
DCP1a (a PB marker) (A-F, green) antibody. Arrowheads indicate representative PB. (G) 
Quantification of PB in mock-infected cells (M) and DV2-infected cells treated (right) or 
not treated (left) with arsenite. PB were counted in 50 cells under each experimental 
condition at the indicated times and the average number of PB/cell was plotted.  Error 
bars indicate the standard deviation of the mean.   
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These results indicate that both WNV and DV2 infections interfere with PB assembly in 
BHK cells. 
 
DISCUSSION 
In normal cells that are not undergoing stress, TIA-1 and TIAR are distributed fairly 
evenly between the cytoplasm and nucleus. In response to stress, TIA-1 and TIAR 
aggregate with cell mRNAs in SG (Kedersha et al., 1999). In the present study, a unique 
distribution pattern for these proteins was observed in cells infected with two different 
flaviviruses, WNV and DV2. First TIAR and then TIA-1 relocated to the perinuclear 
region in flavivirus infected cells. In WNV infected cells, perinuclear foci of TIAR were 
detected by 6 hpi and a significant amount of TIAR were observed in this region by 12 
hpi. With TIA-1, perinuclear foci were not detected until 24 hpi and significant 
concentrations of TIA-1 in this region were not seen until 36 hpi. Interestingly, the 
initiation of TIA-1 relocation to the perinuclear region in infected cells did not begin until 
the majority of TIAR had already relocated to this region. 
By 6 hpi, newly translated viral proteins were detectable in the cytoplasm by 
immunoflourescence and by 12 hpi, the amount of viral protein had increased and was 
concentrated in the perinuclear region. Colocalization of bright foci of TIAR and of viral 
proteins was detected by 6 hpi and the amount of colocalization progressively increased 
thereafter. These bright perinuclear foci also contained dsRNA identifying them as viral 
replication complexes. Previous in vitro RNA-protein binding assays showed that TIAR 
bound 10 times more efficiently than TIA-1 to the WNV 3’(-)SL RNA (Li et al., 2002). 
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The different kinetics of TIA-1 and TIAR redistribution in flavivirus infected cells could 
be due to the more efficient interaction between cytoplasmic TIAR and the 3’ ends of 
viral minus strand RNAs. The 3’(-)SL is thought to contain promoter elements for 
genomic RNA initiation and it was previously proposed that TIAR functions as a 
transcription factor for genomic RNA initiation (Li et al., 2002). This hypothesis was 
recently supported by data showing that mutagenesis of the mapped protein binding sites 
on the WNV 3’(-)SL RNA in a WNV infectious clone negatively affected genomic RNA 
synthesis (Emara and Brinton, unpublished data). Previous analyses of the kinetics of 
flavivirus RNA synthesis showed an initial low peak of genomic RNA synthesis between 
6 and 10-12 hpi followed by a switch to exponentially increasing genomic RNA synthesis 
(Brinton, 2002; Trent, Swensen, and Qureshi, 1969). The level of genomic RNA 
synthesis infected cells correlates temporally with the extent of TIAR relocation to the 
perinuclear region.  
  It was previously shown that the yield of WNV produced by TIAR-/- MEFs, which 
express three times more TIA-1 than wildtype MEFs, was reduced by only 6-to-8 fold as 
compared to TIA-1-/- or control MEFs (Li et al., 2002). These data suggested that TIA-1 
could also function as a viral transcription factor when TIAR was not present. Consistent 
with this hypothesis, colocalization of TIA-1 and WNV proteins in infected TIAR-/- 
MEFs occurred in a time course similar to that observed with TIAR in cells expressing 
both proteins. This data also suggests that the ability of TIA-1 to relocate to the 
perinuclear region is not being actively prevented in infected cells. However, the 
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possibility that TIA-1 is interacting with a cell protein partner and so is not available for 
interaction with viral components until later times after infection can not be ruled out.  
The data suggest the possibility that TIA-1/TIAR may also interact with a viral 
nonstructural protein as well as with the 3’(-)SL RNA. WNV NS3, but not NS5, NS1, or 
E, was co-immunoprecipatated by both anti-TIA-1 and anti-TIAR antibodies. The four 
hydrophobic nonstructural proteins (NS2a, NS2b, NS4a, and NS4b) have been reported 
to be tightly complexed with NS3 in dense membrane fractions (Chu and Westaway, 
1992) while the RdRp NS5 is more loosely associated (Grun and Brinton, 1987). Since 
antibodies to the four hydrophobic proteins were not available, it was not possible to rule 
out an additional interaction between one of these hydrophobic proteins and TIA-1 and/or 
TIAR. Flaviviruses initiate RNA synthesis de novo. The interaction of TIA-1 or TIAR 
with a protein in a flavivirus RdRp complex might enhance the preferential recognition of 
minus strand templates by these complexes. TIA-1/TIAR do not bind to the 3’ terminal 
SL RNA of the genomic (+) RNA template (Emara and Brinton, unpublished data). As 
the number of such complexes progressively accumulates in infected cells, the synthesis 
of genomic RNA would be significantly and preferentially amplified over minus strand 
RNA. The binding of TIA-1/TIAR to the 3’(-)SL RNA might stabilize it allowing other 
necessary factors to assemble and initiation of genomic RNA synthesis to begin. It is 
currently not known whether the self-aggregating domains of TIA-1/TIAR play a role in 
these protein-protein and RNA-protein interactions.  
Flaviviruses are unique among animal positive strand RNA viruses in preventing 
rather than facilitating the shutoff of host cell translation. Flaviviruses replicate at 
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significantly slower rates than most other positive strand RNA viruses in mammalian and 
avian cells, and rapid shutoff of cell protein synthesis with the resulting negative effect 
on cell viability would have a deleterious effect on flavivirus yields. This is the first 
report showing that flavivirus infections do not induce SG formation and that infected 
cells become increasingly resistant to the induction of SG by arsenite treatment with time 
after infection. These data suggest that flavivirus infections actively inhibit SG formation. 
The time course of the resistance to SG formation coincided with that of the relocation of 
TIAR to the perinuclear region rather than with the relocation of TIA-1 or with decreased 
phosphorylation of eIF2α. These observations suggest that the sequestration of TIAR via 
its interaction with the viral 3’(-)SL RNA and possibly also a viral nonstructural protein 
is the initial reason for the observed decrease in SG formation in flavivirus infected cells. 
A previous study showed that although eIF2α was phosphorylated in both TIA-/- and 
TIAR-/- MEFs, SG formation was impaired in TIA-/- MEFs but not in TIAR-/- MEFs, 
suggesting that TIAR alone could not form SG (Gilks et al., 2004). The observation that 
SG formation was inhibited to some extent when TIAR but not TIA-1 was sequestered in 
the perinuclear suggests the possibility that additional components necessary for SG 
formation may also be sequestered in the perinuclear region of flavivirus infected cells. If 
self-aggregation of TIAR in the perinuclear region occurs, this might be what attracts the 
additional SG components. In the previous study that identified TIAR as a WNV 3’(-) 
SL RNA binding protein, three additional cell proteins (p50, p60, and p108) were also 
shown to bind to this viral RNA (Li et al., 2002). Some of these viral RNA binding 
proteins could also be components of SG. The assembly of pseudo-SG complexes around 
  
124
the viral minus strand RNA replication complexes might be part of the remodeling of the 
perinuclear membranes by virus infection to create an environment for efficient genomic 
RNA synthesis and encapsidation.  
Complete resistance to SG induction and a significant decrease in eIF2α 
phosphorylation at S51 were not observed in WNV infected cells until 24 hpi, a time by 
which maximum levels of virus replication had been achieved. Unlike flaviviruses, both 
Semliki Forest virus (SFV), a positive-strand RNA alpha togavirus (McInerney et al., 
2005) and some strains of reovirus, a double-stranded RNA virus (Smith et al., 2006), 
rapidly shut off host cell protein synthesis and induce SG formation via the induction of 
eIF2α (S51) phosphorylation. For both viruses, the phosphorylation of eIF2α as well as 
the aggregation of TIA-1/TIAR into SG were shown to be important for shut off of host 
cell protein translation (McInerney et al., 2005; Smith et al., 2006). In cells subjected to 
environmental stresses, the activation of PKR and/or other cellular kinases leads to the 
phosphorylation of eIF2α (Anderson and Kedersha, 2002a). Activation of PKR followed 
by phosphorylation of eIF2α by PKR and the formation of SG was postulated to result in 
the shut off host cell translation in cells infected with SFV (McInerney et al., 2005; 
Ventoso et al., 2006) or Sindbis virus (Ventoso et al., 2006). The expression of P58IPK, a 
PKR/PERK inhibitor, was shown to be decreased in L929 cells infected with host 
shutoff-inducing strains of reovirus and high levels of phospho-eIF2α were detected 
(Smith et al., 2006). In contrast, in cells infected with two flaviviruses, DV2 or Japanese 
encephalitis virus (MOI of 3), the expression of  P58IPK was significantly upregulated at 
24 hpi (Yu et al., 2006). The timing of this upregulation was exactly coincident with the 
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decrease in eIF2a phosphorylation observed in arsenite treated WNV infected (MOI of 5) 
cells in the present study. Yu et al.(Yu et al., 2006)  also showed that the upregulation of 
P58IPK was the result of activation of the cellular unfolded protein response by the 
accumulation of several different flavivirus proteins in infected cells. The initial shut off 
of SG formation in flavivirus infected cells appears to be due to the sequestration of 
TIAR, and possibly also of other SG components, in the perinuclear region of infected 
cells via interaction with viral components. A direct benefit of this interaction for the 
virus is that it likely facilitates significant amplification of genomic RNA synthesis. An 
indirect benefit is that this interaction inhibits the shut off of host protein synthesis. 
However, flaviviruses appear to utilize multiple mechanisms to inhibit SG formation as 
evidenced by the upregulation of P58IPK at later times after infection mediated by the 
accumulation of viral proteins.   
PB are involved in mRNA degradation and in translational repression (Eulalio, 
Behm-Ansmant, and Izaurralde, 2007). In the present study, a similar decrease in PB 
assembly was observed in both untreated and arsenite treated flavivirus infected cells. 
This decrease was temporally correlated with the initiation of TIA-1 relocation and the 
decrease in eIF2α phsophorylation in arsenite treated cells. The mechanism by which 
flaviviruses interfere with PB assembly in infected cells is not yet known. The 
interference with PB assembly may be related to activation of the unfolded protein 
response and would provide an additional mechanism to prevent translational repression 
and protect viral RNA as well as cell mRNA from degradation.  
 
  
126
MATERIALS AND METHODS 
Cells.   
Baby hamster kidney (BHK-21, strain W12) cells (Vaheri et al., 1965) (referred to as 
BHK cells) were maintained as described previously (Scherbik et al., 2006). C57/BL/6 
and C57/BL/6 TIAR-/- MEF cell lines were provided by Paul Anderson (Brigham and 
Woman’s Hospital, Boston, MA) and grown in MEM supplemented with 10% FCS, 1X 
MEM non-essential amino acids (Invitrogen), 1mM sodium pyruvate (Invitrogen), 2 mM 
glutamine (Invitrogen), and 10 µg/ml of gentamycin.  
 
Viruses.   
A stock of WNV strain Eg101 was prepared in BHK cells (2 x 108 PFU/ml) as 
previously described (Scherbik et al., 2006). DV2, strain Bangkok D80-100 was provided 
by Walter Brandt (Walter Reed Army Institute of Research, Washington, DC). The titer 
of a 10% W/V suckling mouse brain homogenate was 2 x 106 PFU/ml. Cells were 
infected with WNV at a MOI of 5 or 0.1 and with DV2 at a MOI of 0.1. Virus was 
adsorbed to cells for 1 hr at room temperature, the inoculum was removed and the cells 
were washed three times with serum free medium. MEM containing 5% FCS was added 
and the infected cells were incubated at 37oC in a CO2 incubator. To induce stress, cells 
were treated at various times after infection with 0.5 mM sodium m-arsenite (Sigma-
Aldrich St. Louis, Mo.) in MEM for 30 min. Virus growth experiments were done as 
described previously (Li et al., 2002).  
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Antibodies.  
Goat polyclonal antibodies to the C-terminus of TIAR, the C-terminus of TIA-1, 
eIF2α Texas red-conjugated bovine anti-mouse, FITC-conjugated donkey anti-goat, 
FITC-conjugated chicken anti-rabbit, and HRP-conjugated anti-goat, anti-mouse and 
anti-chicken antibodies were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, 
CA). Rabbit polyclonal anti-phospho-eIF2α (serine 51) and anti-rabbit immunoglobulin 
G antibody conjugated with horseradish peroxidase (HRP) were from Cell signaling 
(Beverly, MA), chicken polyclonal anti-G3BP was from Abcam (Cambridge, MA), 
mouse monoclonal anti-dsRNA antibody was from English & Scientific Consulting 
(Szirak, Hungary), and mouse anti-WNV NS3 monoclonal antibody was from R&D 
Systems (Minneapolis, MN). Rabbit anti-human DCP1a serum was a gift from J. Lykke-
Anderson (University of Colorado, Boulder, CO). Mouse anti-WNV hyperimmune serum 
was from Robert Tesh (University of Texas Medical Branch, Galveston, TX). Mouse 
anti-DV2 hyperimmune serum was provided by Walter Brandt (Walter Reed Army 
Institute of Research, Washington, DC).  
 
Western blotting.  
Western blot analysis was carried out as previously described (Scherbik et al., 2006). 
Primary antibodies were diluted in 1X Tris-buffered saline (TBS) containing 5% bovine 
serum albumin (1:1000 for anti-phospho-eIF2α, 1:500 for anti-eIF2α, 1:3000 for anti-
G3BP, and 1:500 for anti-WNV and anti-WNV NS3 antibodies) and the secondary 
antibody was diluted 1:2000 in 1X TBS containing 5% non-fat dry milk (NFDM).  
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Coimmunoprecipitation assays.  
BHK cells (2 x 106) were mock infected or infected with WNV at a MOI of 5. At 24 
hpi, cell lysates were prepared using lysis buffer containing 50 mM sodium phosphate 
(pH 7.2), 150 mM Nacl, 1% NP40, and Complete, Mini, EDTA-free protease inhibitor 
cocktail (Roche). Cell lysates were incubated on ice for 30 min, sonicated, and then 
centrifuged at 2000 xg for 5 min at 4°C. The supernatant (250 µl/ ~100 µg total protein) 
was precleared with protein A/G-magnetic beads (New England Biolabs, Beverly, MA) 
for 1 hr at 4°C with rotation. The clarified supernatants were incubated with 1 µg of anti-
TIA-1 or anti-TIAR antibody at 4°C for 1 hr with rotation, then beads were added and 
incubated for 1 hr. Beads were collected magnetically, washed seven times with 1 ml of 
lysis buffer, and proteins eluted by boiling for 5 min. Proteins were separated by 12% 
SDS-PAGE, transferred to nitrocellulose membranes, and analyzed by Western blotting 
using either mouse anti-WNV or anti-NS3 antibody. 
 
Detection of intracellular and cellular viral proteins by immunofluorescence.  
BHK, C57BL/6, and TIAR-/- cells (2 x 104) were seeded onto 3 mm cover slips 
(Fisher Scientific, Pittsburgh, PA) and grown to about 50% confluency. At various times 
after infection, cells were fixed in 4% paraformaldehyde (Sigma-Aldrich) in PBS for 10 
min at room temperature, permeabilized with 100% chilled methanol for 10 min at -20oC, 
washed three times in PBS and incubated with blocking buffer [PBS containing 5% heat 
inactivated horse serum (Invitrogen)] overnight at 4oC. Primary antibodies were diluted 
in blocking buffer (1:1000 for anti-TIAR, anti-TIA-1 and anti-Dcap1, 1:200 for anti-
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dsRNA, and 1:100 for anti-WNV, anti-DV2 and anti-WNV NS3 antibody) and incubated 
with cells at 37oC for 1 hr. Cells were then washed 3X 10 min with PBS, and incubated 
for 1 hr at 37oC with Texas red-labeled and FITC-labeled secondary antibodies diluted 
1:300 in blocking buffer containing 0.5 µg/ml Hoechst 33258 dye (Molecular Probes, 
Bedford, MA) to stain the nuclear DNA. Cover slips were mounted in Prolong Gold 
antifade reagent (Invitrogen) and the cells were viewed and photographed with a Zeiss 
Confocal Microscope LSM 510 (Zeiss, Germany) using a 100X oil immersion objective. 
The images compared for each experimental series were collected using the same 
instrimuent settings and the images were analyzed using Zeiss software version 3.5. 
 
Laser confocal imaging settings.  
FITC was excited with the 488 nm line of an Argon ion laser, and emitted light was 
collected through a 505-530 nm band-pass filter. Texas red was excited with the 543 nm 
line of a He-Ne laser, and the emitted light was collected through a 560 nm long-pass 
filter. Hoechst 33258 dye was excited with the 364 nm line of an Enterprise laser, and the 
emitted light was collected through a 385-470 nm band-pass filter.  
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